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ABSTRACT 
CONSISTENCY OF DIFFERENTIALLY EXPRESSED GENE RANKINGS 
BASED ON SUBSETS OF MICROARRAY DATA 
DakeYang 
July 21, 2011 
Data derived from gene expression microarrays are frequently used to identify 
candidate genes which can characterize and distinguish between two biological 
phenotypes. A key step in this process is the selection of an appropriate test statistic 
to identify which genes are differentially expressed between the two tissues. 
Although many methods have been explicitly developed for this purpose, the 
traditional (-test still remains a popular choice. In this study, we evaluate the 
empirical impact of choice of test-statistic on the resulting list of differentially 
expressed genes, in particular when the available sample size is small. 
We evaluated several different methods for detecting differentially expressed 
genes (t-test, empirical Bayes, and SAM) using ten different publicly available data 
sets. First, we obtained gene lists based on the full data using the different methods. 
Then, we selected subsamples from the full data, and obtained gene lists based on 
these subsamples. The consistency was quantified using several scores. Factors 
evaluated in the empirical study included the size of the subset and the length of the 
differentially expressed gene list. 
We found that when the sample size of the subset is small, the resulting gene 
list based on the t-test has a very low consistency, while empirical Bayes and SAM 
have much higher consistencies. This result is particularly evident when considering 
only the top ranked genes. When sample sizes are larger, all three methods have the 
III 
same performance. We recommend that investigators use these moderated versions 
in lieu of the t-test when the sample size is small. 
iv 
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DNA microarray is a tool in biotechnology for comparing the expression of 
genes on a genomic scale across two or more samples of messenger RNA (mRNA). 
The microarray consists of thousands of features, which are small DNA 
oligonucleotides. Each feature contains a particular gene sequence, called a probe, 
which allows the microarray to simultaneously monitor the relative expression of 
mRNAs in two or more tissue samples for thousands of genes within the cell. In 
microarray experiments, one common but important question is how to identify those 
genes whose expression level changes across different experimental samples or 
different types of tissue samples (Parrish 2009). Thus, the goal of differential gene 
expression analysis is to determine the genes whose expression level changes 
significantly according to the experimental condition. 
The microarray is a novel tool for comparing the expression of thousands of 
genes, but it also brings to light new statistical problems because of the high 
dimensionality of the data, with a relatively small number of replicates. There are two 
main issues with microarray data (Xu 2009). First, microarray gene expression data 
are commonly considered to be highly noisy, because there are many flaws inherent in 
the current technology. Noise comes from two primary sources in microarray 
experiments, biological noise and technical noise (Tu 2002). Biological noise consists 
of the inherent variation from patient to patient, the variation in the tissues sampled, 
and the variation in the cellular composition of the tissue that is subsequently 
hybridized to the array. Technical noise comes from the differences in sample 
processing and experimental variables. Secondly, microarray data always contain a 
much larger number of genes (usually several thousand or more features) relative to 
the number of samples (usually less than one hundred). With the large number of 
hypothesis tests being conducted and a relatively small sample size, many spurious 
results can appear and many biologically meaningful genes can fail to reach statistical 
significance. In gene expression analysis, a gene is considered differentially expressed 
when its expression level changes systematically between two treatment conditions 
(McCarthy and Smyth 2009). The biological significance is typically measured by the 
relative expression level between the two conditions (the fold-change), while the 
statistical significance is measured by comparison of a test-statistic to a reference 
distribution (the p-value). Ranking of significant genes on the basis of the two 
methods does not always agree, leading investigators to often make comprises 
between the two approaches. 
Due to the huge data volume and inherent variation in microarrays, several 
statistical methods have been proposed to address these problems (Baldi 2001; Efron 
2009). In our paper, we discuss three commonly used methods for identifying which 
genes are differentially expressed between two different experimental conditions or 
tissue types. They are the I-test, the significance analysis of microarrays (SAM) 
(Tusher 2001), and the empirical Bayesian (Smyth 2005) methods. In each case, the 
hypotheses been tested for each gene are the null hypothesis Ho: the gene is not 
differentially expressed between two different experimental conditions or tissue types, 
and the alternative hypothesis HA: the gene is differentially expressed between two 
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different experimental conditions or tissue types. The I-test is a traditional method for 
detecting differentially expressed genes in microarray analysis. The I statistic can be 
used to determine which genes are significantly differentially expressed by comparing 
the test statistic to a t-distribution with n-2 degrees of freedom, where n is the total 
number of microarrays. But in the I-test method, a gene with a low expression level 
but small variance can result in a large absolute I statistic even for small mean 
differences between the two conditions. So this gene can be declared to be 
differentially expressed, even if the difference in expression is not biologically 
meaningful. 
To solve this problem, alternative methods have been proposed. To solve the 
small variance problem of the I-test, SAM modifies the standard 1- statistic by adding 
a small 'fudge factor' to the variance in the denominator. The SAM method compares 
this modified test statistic to an expected value under the null hypothesis, which is 
determined by permutations at the gene expression measurements. Differences 
between observed and expected values which are above a threshold are considered 
statistically significant, where the threshold is determined by the desired false 
discovery rate. Smyth et al. 2004 proposed a similarly derived empirical Bayes 
approach, which shrinks the estimated sample variances towards a pooled estimate. 
Both SAM and empirical Bayes estimators are designed to have robust performance, 
particularly for experiments with small numbers of arrays. 
Although these statistical methods have been proposed as improved methods 
to determine differential gene expression, not too many studies (Haslett 2002; Jeffery 
2006; Hong and Breitling 2008) have empirically compared the performances of these 
different statistical methods. Thus, it is important to evaluate the success of these 
methods through empirical comparisons. The traditional I-test still remains a popular 
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choice among biologists, despite the reputed disadvantages in this method when the 
available sample size is small. So, the goal of this thesis research is to compare and 
evaluate how well the three methods (the (-test, SAM, and empirical Bayes) perform 
with real microarray data. To accomplish this, we evaluate the consistency in 
determining differentially expressed genes for each method, based on numerical 
measures of the degree of overlap between two gene lists (Zhang 2009). Further, we 
evaluate the consistency for each method, when comparing differentially expressed 
gene lists obtained from subsets of two different datasets of the same disease. We 
consider that the methods are performing well in detecting the differentially expressed 
gene lists when the scores are high. We define that one method is better than the other, 
when the scores calculated by one method are higher than other scores from the other 
method under the same situation. 
The rest of this thesis is organized as follows. In Chapter 2, section 2.1 we 
describe the three DEGs (differentially expressed gene) detecting methods (the I-test, 
SAM, and empirical Bayes). In section 2.2, we describe the scores which are used to 
measure the consistency between two gene lists (POG, POGR, nPOG and nPOGR). 
We describe the two groups of data sets for evaluating the consistency of DEdetection 
methods in sections 2.3.1 and 2.3.2. Chapter 3 gives the results from our study, and 




2.1 Methods for detecting the differentially expressed genes 
We selected three popular methods (t-test, empirical Bayes and significance 
analysis of microarrays (SAM» for determining differentially expressed genes (DEGs) 
in microarray data. The standard notations for the three methods we defined as 
follows. Suppose the goal is to detect differentially expressed genes between two 
classes of samples, normal and diseased. Suppose group one (normal) contains n 
samples and the group two (diseased) contains m samples. Suppose there are gene 
expression measurements for all the G genes. For the any given ith gene (i= 1 ,2, ... G ), 
let Xli be the mean of the ith gene expression measurements amongst the samples 
from group one, with corresponding standard deviation S x.' Similarly, define X2i 
I. 
and S x to be the mean and standard deviation of the ith gene expression 
21 
measurements from the samples of group 2. The hypothesis being tested for each of 
genes is Ho: J-lli = J-l2i vs HA : J-lli * J-lZi ' where J-lli and J-l 2i are the population mean 
expression measurements for the gene in the two groups. 
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2.1.1 T -test 
The two-sample t-test on each gene can be used to detect which genes are 
differentially expressed between two classes of samples. The t-statistic for the ith 
gene assuming using a pooled estimator for the standard deviation is defined as 
follows: 
The gene-specific t-test uses only the gene expression values specific to each 
gene to calculate differential expression. Under the null hypothesis, the t-statistic 
follows a t-distribution with approximately n + m -2 degrees of freedom. The P-value 
for the two-sided hypothesis test is calculated as 2P(T,,+m-2 ~ (), where Tn+m-2 
denotes a random variable with a t distribution with n + m - 2 degrees of freedom. The 
null hypothesis is rejected if the P-value is less than the a level of the test. 
2.1.2 SAM (Significance Analysis of Micro arrays) 
With the high levels of noise in microarray data and the small sample sizes, the 
adequacy of the t-statistic is questionable. Since there are a large number of genes 
inmicroarray datasets, there will always be some genes which have a low standard 
deviation by chance. Therefore, these genes will have a large t-statistic and will be 
falsely predicted to be differentially expression genes. Several authors have proposed 
improvements on the t test for genome-wide expression measurements. 
To improve upon the deficiencies of the t-test mentioned above, Tusher 
(Tusher 2001) proposed the significance analysis of microarrays (SAM) method to 
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select differentially expressed genes by adding a small, strictly positive constant So, 
(the so called fudge factor) to the denominator of the usual t-statistic. Define gene 
specific "relative differences" d;(i = 1,2, ... G) and gene specific standard deviations 
S;(i = 1, 2, ... G). 
d = X I;-X2; 
I S; +So 
IIn+lIm n - 2 m - 2 
S; = {~)Xlij -Xli) + ~)X2ij -X2;) } 
n+m-2 J=I j=1 
The fudge factor So is calculated by minimizing the coefficient of variation of d; as a 
function of S; (Tusher 2001). A permutation procedure is used to calculate the 
P-value for each gene. 
DE genes are determined by comparing the observed relative differences d; 
with the expected relative differences d;E, where d;E are calculated by averaging the 
relative differences from permutations of the data. Genes with differences between 
observed and expected values greater than a threshold ~ are declared statistically 
significant. The threshold ~ is a user controlled parameter, and SAM provides an 
estimate of the FDR (false discovery rate) for each ~ value. 
2.1.3 Empirical Bayes 
A hierarchical model (Smyth 2004; Smyth 2005) is used to model distribution 
of the variances and differences in mean expression between the two tissue types for 
each gene. Based on the hierarchical model for the variances, for each gene, a 
posterior estimate of the population variance a} for each gene, given the sample 
7 
variance Sj2, is obtained. This expectation is termed §~, and is calculated as a 
weighted average of the prior variance S~ and the sample variance Sj2, 
8~ = doS; + d;S;2 , 
do+d; 
Where do is the degrees of freedom for the prior distribution of S;2 and d; is the 
degrees of freedom for the ordinary I-statistic. The moderated I-statistic is then 
defined as 
The moderated I-statistic follows a I-distribution with d; + do degrees of freedom, 
under the null hypothesis. 
2.2 POG and POGR scores 
In this section, we define the metrics used to measure the consistency between 
two gene lists. For example, two separate lists of differentially expressed genes 
produced by independent studies of the same disease. A relatively straightforward 
metric is the percentage of overlapping genes (PO G) metric, which has been used by 
numerous previous studies (Shi 2006; Chen 2007). The POG measures the 
consistency of two separate gene lists by determining the percentage of overlapped 
genes between the two lists. Specifically, assume that n genes are shared between list 
1 with length II' and list 2 with length 12 , The calculation of the POG score depends 
on which list is determined to be the 'reference' list, i.e. the POG between list 1 and 
list 2 is POGI2 =!!.. and the POG between list 2 and list 1 is POG21 =!!.... The POG is 
~ 4 
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a useful metric to evaluate the reproducibility of gene lists from independent studies, 
and has been previously used to measure the consistency of gene lists obtained from 
separate studies of the same disease (Zhang 2009). We can also consider the POG 
score as equivalent to a popular index of diagnostic accuracy, the sensitivity. 
To see this, assume that the reference list (say, list 1) contains the 'true' 
differentially expressed genes, equivalent to the individuals which truly have the 
disease of interest in the evaluate of a diagnostics test. Then, the length of list 1 (II) is 
the same as the denominator of the sensitivity, and the length of the overlap of the two 
lists (n) is the same as the numerator of the sensitivity. 
An extension to the POG score, called the percentage of overlapping 
genes-related or POGR score, considers not only those genes which are shared 
between the two lists, but also those genes which are highly correlated with each other. 
The motivation here is to consider a measure of the reproducibility of gene lists, 
which accounts for the coordinated molecular changes which frequently occur in 
biological systems. Similar to the POG score, the POGR (percentage of overlapping 
genes-related) metric is used to evaluate the consistency between two gene lists. Let 
nrl2 (or nr21 ) represent the number of genes between two lists which are not shared 
but are significantly correlated. Here, two genes are defined as a correlated pair if and 
only if they are significantly correlated in both datasets. Then, the formula for the 
POGR scores are, 
Both the POG and POGR are in the range of 0 to 1. Generally, a high POG or 
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POGR score is wanted between two lists. A problem with both, however, is that they 
are positively correlated with the length of the lists. Further, when the expressed 
genes are highly correlated with each other in a biological system, the POGR score 
between two randomly selected gene lists can be high, since nrl2 (or nr21 ) may be 
high. This is because that, when the genes are highly correlated, the nrl2 maybe high. 
To solve this problem, Zhang et ai, (2009) introduced normalized versions of the POG 
and POGR scores (nPOG, nPOGR), where described below. 
Define E(n) as the expected number of the shared genes between two 
randomly generated lists with lengths II and 12 lists. Then, the expected POG is 
The normalized POG is similar in calculation to the kappa coefficient, which 
represents a chance-corrected index of agreement between categorical variables. The 
E(POG12) [or E(POG21 )] can be estimated by simulation, by averaging the POG 
scores fromlO,OOO pairs of randomly generated lists (with lengths h and h). 
Randomly selected lists oflength h (or h) can be generated by drawing II (or h) genes 
without replacement from the complete list of genes. The POG as the ratio of the 
observed scores to the maximum potential scores as follows: 
nPOG _ POGI2 -E(POGI2 ) _ n-E(n) 
12 - -
1- E(POGI2 ) II - E(n) 
POG 
= POG21 - E(POG21 ) _ n - E(n) n 21 -
l-E(POG21 ) 12 -E(n) 
We can normalize the POGR score in a similar way. The E(POGRI2 ) or 
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[E(POGlS I )] can be calculated by adding the expected number of correlated genes 
between the two lists, E(nrd [or E(nr2l)], to the expected number of overlapped genes, 
E(n). So, the normalized POGR score is 
nPOG = POGRI2 -E(POGRI2 ) = n+nrl2 -E(n)-E(nrI2) 
12 l-E(POGRI2 ) 'I -E(n)-E(nrI2 ) 
or 
nPOG = POGR21 -E(POGR21 ) = n+nr21 -E(n)-E(nr21) 
21 l-E(POGR21 ) '2 -E(n)-E(nr21 ) 
The nPOGR score corrects for chance agreement, and removes the effects of 
the length of the gene lists and data correlations. Hence, the score may be more 
appropriate for comparing the consistency levels between differentially expressed 
gene lists with different lengths and from different studies. 
2.3 Study Design 
2.3.1 Consistency of DE (differentially expressed) detection methods within a 
single dataset. 
Four datasets of different diseases were used to evaluate the consistency of 
methods to detect differential expression, based on subsets of the same data (Table 1). 
Before all the procedures we filtered the raw data to remove invariant transcripts , 
using the 'nsFilter' command in the' genefilter' R package. 
Transcripts were filtered using the 'var.cutoff with the value set to 0.5, so that all 
genes with a variance below 0.5 were removed. This is motivated by the observation 
that in many tissues only 40% of the genes are expressed. We additionally set the 
II 
Raw Size Used Size 
Data set Reference Analysis(number) Platform 
Samples x Genes Samples x Genes 
ALL Sabina et at, 2004 128x 12625 79x4399 BeR/ABL(37), NEG(42) Affymetrix 
ColonCA Alon et aL, 1999 62x2000 62x2000 Tumor(40), Normal(22) Affymetrix 
1ungExpression Beer et aL, 200:z 86x3171 86x3171 death(24),live(62) Affymetrix 
golubEsets Golub et aL, 1999 72x7129 72x2698 ALL(47), AML(25) Atfymetrix 
Table 1. Details of four data sets used to study consistency of DE detection methods 
within a single data set. 
argument 'remove.dupEntrez=TRUE', so that for transcripts mapping to the same 
Entrez Gene ID, the transcript with the largest variance will be retained and the others 
removed. 
The ALL (Acute Lymphoblastic Leukemia) data from the Ritz 
Laboratory(Sabina 2004), consists of 128 samples. We selected 79 samples 
representing two molecular biology subtypes, BCRJABL (an oncogene fusion protein 
consisting of BeR and ABL genes) (37 samples) and NEG (42 samples). After 
screening out invariant expression profiles, the final number of probes in the data set 
was 4,399. The CoionCA data contains 2,000 expression measurements from 40 
colon cancer tumor samples and 22 normal samples (Alon 1999). The lungExpression 
data (Beer 2002) consists of 3,171 expression measurements from 86 lung cancer 
patients, of whom 62 were alive at the end of the study and 24 had died. The 
golubEsets data (Golub 1999)are the combined training samples and test samples. 
There are 47 patients with acute lymphoblastic leukemia (ALL) and 25 patients with 
acute myeloid leukemia (AML). The samples were assayed using Affymetrix 
Hgu6800 chips and data on the expression of 7129 genes (Affymetrix probes) are 
available. After screening out invariant probes, a total of 2,698 probes remained. All 
data sets were stored as normalized gene expression format (class exprSet) in 
12 
Bioconductor. 
To evaluate the consistency of the three DE detection methods, we randomly 
selected a varying number of subsets without replacement from the full data (Four 
different numbers of subsets were used for each data set). Here we ignored the 
possible dependency between samples from the same group (diseased / normal) in the 
design, implicitly assuming that the samples from within a single group were 
independent. Next, we used three methods to detect the differentially expressed genes 
lists based on both the subsets and the full data. The genes were then ranked on the 
basis of the absolute values of their test statistics. Next, we used different lengths of 
lists to calculate the scores we defined in section 2.2 (POG, nPOG, POGR and 
nPOGR). We repeated the three steps above 100 times, and calculate the mean of each 
of scores, for each combination of method, dataset, subset length, and list length. 
2.3.2 Consistency of DE detection methods between data sets 
Six datasets for three diseases were analyzed to evaluate the consistency of 
subsets from different data sets that were collected for the same disease. The prostate 
cancer cDNA microarray data consists of 62 tumors and 41 normal prostate samples 
measured for 46,205 clones (Lapointe 2004). After screening out invariant expression 
profiles, the final number of probes in the data set was 20,540. While the oligo 
microarray (Affymetrix U95Av2) data contain 52 tumor and 50 non-tumor 
samples(Singh 2002). After screening out invariant probes, a total of 4,399 probes 
remained. For lung cancer, the cDNA microarray data consist of 13 squamous cell 
lung cancer and five normal lung specimens(Garber 2001), and 13,822 probes 
remained after screening. While the data by Affymetrix human U95A oligonucleotide 
Data set Refereoce Raw Size u.ed Size Aoaly.i.(oumber) 
13 
Samples x Genel Samples x Genes 
pro.tate cancer Lapointe et ai., 2004 103 x46,205 103 x20540 Tumor(62), Norrnal(41) eDNA 
pro.tate cancer Singh et aI., 2002 102 x 12600 102 x4399 Tumor(52), Norrnal(50) AtTymetrix 
lung cancer Garber et aI., 2001 123 x24000 123 x l3822 Tumor(67), Norrnal(56) eDNA 
lung cancer Bhattacharjee et aI., 2001 203 x 12600 203 x4399 Tumor(186), Norrnal(17) Affymetrix 
Duchenoe mu.tular dy.trophy Haslett et aI., 2002 23 x 12625 23 x4399 DMD(I2), Norrnal(ll) AtTymetrix 
Duchenne muscular dystrophy Pescatori et aI., 2007 37 x22283 37x6352 DMD(23), Control(14) AfTymetrix 
Table 2. DetaIls of SIX data sets used to study consistency of DE detectlOnmethods 
between different datasets for one disease. 
arrays consist of 21 squamous cell lung carcinomas and 17 normal lung 
specimens(Bhattacharjee 2001). After screening, the final number of probes in the 
data was 4,399. The two datasets for Duchenne muscular dystrophy (DMD) are based 
on Affymetrix (Santa Clara, CA) HG-U95Av2 and HG-U133A GeneChips, 
respectively. One dataset contains 24 samples from 12 DMD patients and 12 
unaffected controls(Haslett 2002), and the other consists of 36 samples from 22 DMD 
patients and 14 controls (Pescatori 2007). After screening, there were 4,399 and 6,352 
probes remained for the two data sets. For each disease, we only analyzed the genes 
that were present on both platforms. The cDNA data were log base 2 transformed and 
then normalized as median 0 and standard deviation 1 per array. The Affymetrix 
GeneChip data were normalized by RMA (Robust Multi-array Analysis). 
We again used three methods (t-test, empirical Bayes and SAM) to detect the 
the differentially expressed gene lists from each dataset. To begin, we measured 
overlap genes from the two data sets of one disease. And the overlap genes are the 
interesting genes which we detected differentially expressed genes from. Second, we 
randomly selected a varying number of subsets without replacement from the two data 
sets for one disease (Four different numbers of subsets were used to each data set). 
We assumed that the samples in the same group were independent. Next, we used 
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three methods (t-test, empirical Bayes and SAM) to detect the differentially expressed 
gene lists from the two subsets of the two datasets. Genes were subsequently ranked 
on the basis of the absolute values of their test statistics. And then, we used different 
lengths of lists to calculate the scores we defined in section2.2 (POG, nPOG, POGR 
and nPOGR). We repeated the three steps above 100 times, and calculate the mean of 
each of scores, for each combination of method, dataset, subset length, and list length. 





3.1 Consistency of DE detection methods using subsets from the same data set 
For the four datasets from the Biocuductor website, we compared the 
differentially expressed gene lists determined using subsets from the same dataset to 
test the consistency of the three methods. For the ALL dataset, we obtained various 
lengths of differentially expressed gene lists using the three methods (t-test, empirical 
Bayes and SAM) for different sample sizes. We separately chose subsets of size 3, 6, 
10 and 25 randomly and without replacement each from 37 BCRJABL and 42 NEG 
samples (total sample size of 6, 12, 20 and 50 samples, respectively). Test statistics 
for differential gene expression between the two tissue types for each gene were 
calculated using each of the three methods. Then, different lengths of gene lists, 50, 
100, 500 and 1000, were used to test the overlap of genes with the gene lists taken 
from the full data. 
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POG score for ALL 
Method length/subset 50 100 500 1000 
T-test 6 0.070 0.088 0.195 0.299 
10 0.098 0.138 0.260 0.347 
20 0.266 0.327 0.421 0.475 
50 0.578 0.625 0.677 0.696 
Empirical Bayes 6 0.132 0.168 0.240 0.331 
10 0.152 0.192 0.289 0.365 
20 0.306 0.368 0.439 0.485 
50 0.582 0.642 0.682 0.700 
SAM 6 0.166 0.187 0.256 0.343 
10 0.167 0.205 0.298 0.373 
20 0.353 0.397 0.455 0.492 
50 0.619 0.695 0.695 0.711 
Table 3 POG score for ALL data set 
The POG scores for the ALL data are in Table 3. From Table 3 we found that 
the POG scores were low when the length of the lists and the number of the subsets 
were small. The POG scores increased with larger subsets or longer length of the gene 
lists. Then, we discovered from the data that, the values under the (-test were 
generally smaller than the values from other two methods. It was more distinct when 
the length of the lists and the number of the subsets were small. And the values 
converged to each other when the length of the lists and the number of the subsets 
went up. 
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POGR score for ALL 
Method length/subset 50 100 500 1000 
T-test 6 0.463 0.570 0.821 0.908 
10 0.542 0.642 0.848 0.923 
20 0.826 0.852 0.905 0.946 
50 0.930 0.937 0.956 0.970 
Empirical Bayes 6 0.665 0.725 0.845 0.919 
10 0.681 0.740 0.864 0.926 
20 0.878 0.874 0.909 0.948 
50 0.946 0.946 0.954 0.969 
SAM 6 0.690 0.740 0.859 0.928 
10 0.699 0.747 0.869 0.931 
20 0.895 0.882 0.917 0.954 
50 0.963 0.947 0.957 0.975 
Table 4. POGR scores for ALL data 
The POGR scores for the ALL data are showed in Table 4. The result of 
POGR score was quite similar to the POG score. The POGR scores are uniformly 
higher than the POG scores, reflecting the strong correlation between the genes in the 
data set. However, the effect of subset size, length of list, and choice of DE detection 
method were all similar to the POG score results. 
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nPOG score for ALL 
Method length/subset 50 100 500 1000 
T-test 6 0.057 0.066 0.094 0.093 
10 0.086 0.117 0.164 0.154 
20 0.258 0.313 0.347 0.319 
50 0.573 0.616 0.636 0.607 
Empirical Bayes 6 0.120 0.148 0.144 0.135 
10 0.141 0.172 0.197 0.178 
20 0.298 0.355 0.368 0.332 
50 0.576 0.633 0.642 0.613 
SAM 6 0.155 0.166 0.162 0.151 
10 0.156 0.185 0.207 0.189 
20 0.345 0.385 0.386 0.342 
50 0.614 0.687 0.656 0.626 
Table 5. nPOG scores for ALL data 
The nPOG scores for the ALL data are showed in Table 5. From Table 5, we 
found that the nPOG scores were low when the number of the subsets was small. And 
the nPOG scores went up when the subsets became larger. But, the nPOG score was 
not affected by the length of the gene list. Also, we found that, the values under the 
(-test were smaller than the values from the other two methods. It was more distinct 
when the number of the subsets was small. And the values approached each other 
when the subsets size increased. So, in general the empirical Bayes and SAM methods 
performed better than (-test. 
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nPOGR score for ALL 
Method subsetJIeogth 50 100 500 1000 
T-test 6 0.047 0.045 0.040 0.025 
10 0.078 0.100 0.l13 0.091 
20 0.253 0.300 0.309 0.270 
50 0.567 0.609 0.617 0.584 
Empirical Bayes 6 0.112 0.129 0.098 0.078 
10 0.131 0.155 0.150 0.121 
20 0.292 0.342 0.331 0.285 
50 0.571 0.626 0.622 0.593 
SAM 6 0.147 0.151 0.113 0.099 
10 0.147 0.172 0.158 0.137 
20 0.339 0.374 0.349 0.301 
50 0.609 0.683 0.637 0.610 
Table 6. nPOGR scores for ALL data. 
The nPOGR scores for the ALL data are showed in Table 6. The result for 
nPOGR score was similar to the nPOG score. The nPOGR scores were all similar in 
magnitude to the nPOG scores, reflecting the fact that normalization accounts for the 
strong gene-gene correlations present in this data. 
Then, we studied the consistency of relatively small-scaled experiments for 
colon cancer with 62 samples (40 tumor samples, 22 normal samples). We detected 
differentially expressed genes by different sample size and length of gene lists using 
the three DE detection methods. We chose subsets of total size 6, 12, 27 and 51 
randomly and without replacement from the 40 tumor samples and 22 normal samples. 
The subsets were chosen in a 2: 1 ratio. Then, we used different length of gene lists, 50, 
100, 500 and 1000 to test the overlap between the gene lists taken from the full data 
and the gene lists based on the subset. The results for the POG, POGR, nPOG and 
nPOGR scores are given in 'Appendix A', Table 1- 4. Overall, the results are similar 
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to those from the ALL data, expect that the difference between the three DE detection 
methods is smaller. 
Third, for the lung expression data, it contains 86 samples of whom 62 were 
alive at the end of the study and 24 had died during the study. We detected 
differentially expressed genes by different sample sizes and length of gene lists using 
the three DE detection methods. We chose total subset size of 8, 12, 28 and 48 
samples randomly and without replacement each from the complete dataset. The 
subsets were chosen in a 3: 1 ratio from amongst those who lived versus those who 
died during the follow-up period. Then, we used different length of gene lists, 50, 100, 
500 and 1000 to test the overlap genes with the gene lists taken from the full data. The 
results for the POG, POGR, nPOG and nPOGR scores of lung expression data are 
given in 'Appendix A', Tables 5- 8 and are similar to the ALL and colon cancer data. 
Finally, for the Leukemia data, 47 patients with acute lymphoblastic leukemia 
(ALL) and 25 patients with acute myeloid leukemia (AML) were monitored in the 
experiment. We chose total subset size of 6, 12, 27 and 51 samples randomly and 
without replacement from the complete. The subsets were chosen in a 2: 1 ratio of 
ALL to AML patients. Then, we used different lengths of gene lists, 50, 100, 500 and 
1000 to test the overlap between gene lists based on the full data and gene lists based 
on the subsets. The results for the POG, POGR, nPOG and nPOGR scores of 
Leukemia data are given in 'Appendix A', Table 9-12. The results were similar to the 
three datasets above. 
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Table 7 summarizes the results from the four datasets, and shows the average 
nPOG scores over the four lengths of the gene lists from the four datasets. Figure 1 




6 10 20 50 
T-test 0.077 0.130 0.309 0.608 
eBayes 0.137 0.172 0.338 0.616 
SAM 0.159 0.184 0.364 0.646 
Methods/Subsets 
Colon Cancer 
6 10 20 50 
T-test 0.133 0.271 0.499 0.759 
eBayes 0.175 0.294 0.510 0.764 
SAM 0.182 0.301 0.528 0.775 
Methods/Subsets 
Lun2 Expression 
6 10 20 50 
T-test 0.051 0.098 0.168 0.332 
eBayes 0.069 0.117 0.179 0.337 
SAM 0.088 0.137 0.205 0.352 
Methods/Subsets 
Leukemia 
6 10 20 50 
T-test 0.176 0.297 0.572 0.762 
eBayes 0.228 0.326 0.583 0.767 
SAM 0.253 0.349 0.626 0.803 
Table 7. The summarize of the nPOG scores for four data sets used to study 
consistency of DE detection methods within a single data set. 
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nPOG score for detecting DEG lists from the same data set 














Figure I. The figure of the nPOG scores for four data sets used to study consistency 
of DE detection methods within a single data set. 
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Table 8 summarizes the results from the four datasets, and shows the average 
nPOGR scores over the four lengths of the gene lists from the four datasets. Figure 2 
plots to the nPOGR scores listed in table 8 and the cutoff = 0.8 . 




6 10 20 50 
T-test 0.039 0.096 0.283 0.594 
eBayes 0.104 0.139 0.313 0.603 
SAM 0.128 0.153 0.341 0.635 
Methods/Subsets 
Colon Cancer 
6 10 20 50 
T-test 0 0 0.431 0.773 
eBayes 0 0.030 0.449 0.783 
SAM 0 0.048 0.473 0.784 
Methods/Subsets 
Lung Expression 
6 10 20 50 
T-test 0 0 0.061 0.249 
eBayes 0 0.014 0.077 0.257 
SAM 0 0.048 0.122 0.286 
Methods/Subsets 
Leukemia 
6 10 20 50 
T-test 0.392 0.515 0.708 0.851 
eBayes 0.455 0.543 0.718 0.854 
SAM 0.487 0.575 0.754 0.878 
Table 8. The average of the nPOGR scores for four data sets used to study consIstency 
of DE detection methods within a single data set. 
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nPOGR score for detecting DEG lists from the same data set 
eBayes · SAM ~ t·test + 
10 II 





















Figure 2. The plot to the nPOGR scores for four data sets in Table 8. 
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3.2 Consistency of DE detection methods from different data sets of the same 
disease. 
For the six datasets of three diseases (prostate cancer, lung cancer, and DMD), 
we compared the differentially expressed gene lists from the two datasets for the same 
disease to test the consistency of the three DE detection methods. 
First, for the prostate cancer data, here are 103 samples III the cDNA 
microarray data, which are divided into two parts, 62 tumor samples and 41 normal 
prostate samples. For the Affymetrix microarray data, there are 52 tumor and 50 
non-tumor samples. A total of 2262 genes were found to be in common between both 
platforms. We considered these 2262 genes to be the complete data in both to cases, 
as the whole gene lists of interest. Then, we randomly picked subset of 3, 5, 10 and 25 
samples from the tumor and normal tissue samples for each of the two data sets. Then, 
we separately used three methods to detect the differentially expressed gene lists from 
two subsets of the full data. Third, we use different lengths of lists 50, 100, 500, 1000 
to calculate the POG, POGR, nPOG and nPOGR scores. We repeated the same 
procedure for 100 times, and calculated the mean of the 100 scores. 
26 
nPOG score for Prostate Cancer 
Method subsetllength 50 100 500 1000 
T-test 6 0.014 0.019 0.033 0.023 
10 0.036 0.036 0.031 0.023 
20 0.076 0.090 0.083 0.040 
50 0.085 0.088 0.085 0.057 
Empirical Bayes 6 0.039 0.049 0.056 0.027 
10 0.049 0.049 0.041 0.034 
20 0.086 0.103 0.090 0.042 
50 0.084 0.093 0.101 0.066 
SAM 6 0.031 0.041 0.054 0.028 
10 0.043 0.046 0.040 0.039 
20 0.083 0.101 0.090 0.043 
50 0.082 0.083 0.089 0.070 
Table 9. nPOG score for Prostate Cancer 
nPOGR 0.8 score for Prostate Cancer 
From cDNA to Affymetrlx From Affymetrlx to cDNA 
Method subsetllength 50 100 500 1000 50 100 500 1000 
T-test 6 0.087 0.071 0.033 0.005 0.082 0.062 0.023 0.001 
10 0.136 0.104 0.037 0.007 0.116 0.092 0.041 0.006 
20 0.15 0.114 0.059 0.019 0.122 0.105 0.049 0.011 
50 0.351 0.217 0.099 0.039 0.333 0.204 0.089 0.026 
Empirical 6 0.194 0.188 0.081 0.009 0.168 0.188 0.186 0.128 
Bayes 10 0.234 0.212 0.121 0.034 0.177 0.19 0.179 0.137 
20 0.394 0.405 0.223 0.087 0.188 0.201 0.193 0.142 
50 0.531 0.511 0.272 0.085 0.341 0.301 0.27 0.171 
SAM 6 0.199 0.183 0.083 0.014 0.145 0.165 0.175 0.122 
10 0.225 0.199 0.113 0.029 0.224 0.228 0.183 0.108 
20 0.366 0.385 0.211 0.073 0.243 0.272 0.242 0.155 
50 0.474 0.492 0.246 0.061 0.262 0.301 0.364 0.254 
Table 10. nPOGR score for Prostate Cancer with the cutoff= 0.8. 
The nPOG and nPOGR scores for the prostate cancer data are showed in Table 9 and 
10 respectively. From Table 9, the nPOG scores were very low for all subset sizes, 
indicating low consistency between the two data sets, irrespective of the DE detective 
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method. From Table 10, the nPOGR scores were generally higher than the nPOG 
scores, although there appears to be an anomaly in that the nPOGR scores decrease 
with the length of the list, contrary to what was expected. In both c·ases, the scores 
increased when the subsets became larger. Also, we found that, the values under the 
(-test were smaller than the values from the other two methods. It was more distinct 
when the number of the subsets was small. The values converged to each other when 
the number of the subsets increased. 
For the lung cancer data, there are 18 samples in the cDNA microarray data, 
which are divided into two parts, 13 tumor samples and 5 normal prostate samples. 
For the Affymetrix microarray data, there are 21 tumor and 17 non-tumor samples. A 
total of 1893 genes were found to be in common between the both platforms. We 
considered these 1893 genes to be the complete data in both to cases. Then, we 
randomly picked subsets of 4, 8, 12 and 16 samples from the tumor and normal tissue 
samples for each of the two data sets. For cDNA data, the subsets were chosen in a 
3: 1 ratio of tumor to normal samples. For Affymetrix data the subsets were chosen in 
a 1: 1 ratio of tumor to normal samples. Then, we separately used three methods to 
detect the differentially expressed gene lists from two subsets of the full data. Third, 
we used different lengths of lists 50, 100, 500, 1000 to calculate the scores. At last, 
we repeated the same procedure 100 times, and calculated the mean of the 100 scores. 
The results for the nPOG and nPOGR scores of lung cancer data are given in 
'Appendix A', Table 13-14. The scores are generally higher compared to the prostate 
cancer data, and the differences between the (-test and the other two methods are more 
pronounced, for the nPOG score. The rest results are similar to the prostate cancer 
data sets. 
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For the duchenne muscular dystrophy (DMD) data, there are 24 samples in the 
first Affymetrix data, which are divided into 12 DMD patient samples and 12 control 
samples (Haslett et al., 2002). For the other Affymetrix there are 22 DMD patient 
samples and 14 control samples (Pescatori et al., 2007). A total of 3158 genes were 
founded to be common between both data sets. We considered these 3158 genes to be 
the complete data in both data sets. Then, we randomly picked subsets of 6, 8, 12 and 
24 samples for each of the data sets without replacement. For Haslett's data, the 
subsets were chosen in a ratio of 1: 1 between patients and normal samples, and the 
subsets were selected in a ratio of 2:1 between patients and controls in Pescatori's 
data. Then, we separately used three methods to detect the differentially expressed 
gene lists from two subsets of the full data. Third, we used different lengths of lists 50, 
100, 500, 1000 to calculate the POG, POGR, nPOG and nPOGR scores. We repeated 
the procedure 100 times, and calculated the mean of the 100 scores. The results for 
the nPOG and nPOGR scores of lung cancer data are given in 'Appendix A', Table 
15-16. The result was almost same to the lung cancer data sets. 
Table 11 and 12 give the average nPOG and nPOGR scores for each of the 
three data sets, covered over the four subsets sizes. Figure 3 plots the nPOG scores 




6 10 20 50 
T-test 0.022 0.032 0.072 0.079 
eBayes 0.043 0.043 0.080 0.086 
SAM 0.039 0.042 0.079 0.081 
Methods/Subsets 
Lung Cancer 
4 8 12 16 
T-test 0.144 0.152 0.195 0.224 
eBayes 0.205 0.208 0.240 0.260 
SAM 0.210 0.214 0.248 0.273 
Methods/Subsets 
DMD 
6 12 18 24 
T-test 0.119 0.265 0.342 0.400 
eBayes 0.251 0.335 0.389 0.447 
SAM 0.240 0.335 0.395 0.449 
Table 11. The summanze of the nPOG scores for SIX data sets used to study 
consistency of DE detection methods between different data sets of the same disease. 
nPOG score for detecting DEG lists from different data sets of the same diseases 
eBayes · SAM " t·test + 
• 8 12 18 2. 50 
DMD Luna cancer Prostate cancer 
0.2 
01 
4 8 12 18 24 50 4 8 12 18 2. 50 
subset 
Figure 3. The plot of the nPOG scores for six data sets in Table 11. 
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nPOGRO.75 
From Data A to Data B From Data B to Data A 
Methods/Subsets Prostate Cancer Prostate Cancer 
6 10 20 50 6 10 20 50 
T-test 0.049 0.071 0.086 0.177 0.042 0.064 0.072 0.163 
eBayes 0.118 0.15 0.277 0.35 0.168 0.171 0.181 0.271 
SAM 0.12 0.142 0.259 0.318 0.152 0.186 0.228 0.295 
Methods/Subsets 
Lung Cancer Lung Cancer 
4 8 12 16 4 8 12 16 
T-test 0.064 0.081 0.139 0.196 0.081 0.099 0.148 0.196 
eBayes 0.332 0.339 0.378 0.406 0.286 0.294 0.34 0.358 
SAM 0.339 0.345 0.387 0.409 0.292 0.302 0.34 0.359 
DMD DMD 
Methods/Subsets 
6 12 18 24 6 12 18 24 
T-test 0.158 0.185 0.213 0.263 0.16 0.191 0.254 0.285 
eBayes 0.472 0.545 0.585 0.61 0.485 0.565 0.613 0.656 
SAM 0.461 0.543 0.585 0.603 0.466 0.558 0.612 0.655 
Table 12. The summarIze of the nPOGR scores for six data sets used to study 
consistency of DE detection methods between different data sets of the same disease, 
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In our article, three distinct methods were used for selecting differentially 
expressed genes, the t-test, empirical Bayes and SAM. The calculation of the test 
statistic for each method captures different aspects of the changes in expression 
measurements for each gene, resulting in potentially different lists of DE genes. The 
traditional t-test still remains a popular choice, and we compared the t-test with the 
empirical Bayes and SAM methods to evaluate the empirical impact of choice of 
test-statistic on the consistency of the resulting list of differentially expressed genes. 
Of particular interest was the consistency of each method when the available sample 
size was small. 
Based on our results, the traditional t-statistic had the poorest performance 
relative to SAM and the empirical Bayesian methods. This was particularly evident 
in the studies involving two data sets for the same disease, although less evident for 
the studies involving subsets of a single data set. The t-statistic can be unstable in 
small data sets, because the variance estimate can be quite skewed by outlying 
expression values. Further, due to the large numbers of genes in microarray datasets, 
there will always be some genes with low standard deviation by chance. In this case, 
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these genes will have large t-statistics and would be considered to be 
differentially expressed falsely. In this case, the empirical Bayes and SAM statistics, 
which can be considered as modified t-statistic methods, gave better results. 
When the length of the gene lists increased, the POG and POGR scores 
generally increased. But for the nPOG and nPOGR scores, the values of the scores did 
not change uniformly with the length of the lists. and the degree of change was 
smaller than for the POG and POGR scores. So, the POG and POGR scores are more 
strongly affected by the length of the gene list, and the nPOG and nPOGR scores 
are more appropriate to evaluate the consistency of DE detection methods with 
different lengths of lists. Next, we found that all the scores increased when the size of 
the subsets increased. We can conclude that the sample size is important when 
evaluating the consistency of the DE detection methods. In the first part of the 
experiment, we compared the differentially expressed gene lists from different 
subsamples with the full data in the same study to avoid any platform and site 
differences. According to our result, the differentially expressed gene lists can still be 
very inconsistent, especially when the subsets were small. 
The DE gene lists from small-scaled microarray studies may only contain a 
small portion of the total number of differentially expressed genes in a disease, so the 
POG scores will generally be low. However, each differentially expressed gene list 
may include mostly true genes. Usually, the global expression changes of genes in a 
disease may introduce great uncertainty to the findings at the individual gene level 
(Jeffery 2006). In this case, even if there are many 'true' differentially expressed 
genes in a disease, we may be only discovering the most significant ones. Thus, the 
POGR score is helpful for measuring how well different methods for detecting DE 
genes retain the biologically important genes, particularly when considering small 
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subsets of the samples. As the result, when the sample size of the microarray study is 
small, the nPOGR score may give the best result. 
According to the result we got, we used the nPOG and nPOGR scores to 
evaluate the efficacy of the methods. These three methods were then applied to ten 
real microarray data sets. Our results indicated that SAM was the most consistent 
method in the analysis of all the data sets, although the empirical Bayes method 
performed similarly to SAM. When the sample size of the subset was small (3 arrays 
per group), the resulting gene list based on all three mehods had a low consistency 
with the gene list based on the full data, although the empirical Bayes and SAM 
methods had higher consistencies relative to the t-test. 
This disparity between the methods is more apparent when considering the studies 
using two different data sets for the same disease. In this case, both the SAM and 
empirical Bayes methods had considerably higher consistencies relative to the t-test. 
In light of all the evidence, we recommend that investigators use these moderated 
versions in lieu of the t-test when the sample size is small (less than 5 per group). 
There are several limitations with our study that are planned as areas of future 
research. First, our findings suggest that the moderated versions of the t-test are more 
consistent than the traditional t-test for microarray studies. One aspect which we did 
not explicitly evaluate is how robust each of the methods are to departures from 
normality. Both SAM and the empirical Bayes t-test are moderated by adding a 
strictly positive constant to the denominator of the ordinary t-statistic. The addition of 
this constant reduces the chance of 'detecting' genes (declaring them to be statistically 
significant) which have a low standard deviation by chance. Since common departures 
from normality (skewness and/or outliers) would inflate the sample variance, this 
suggests that the moderated versions of the t-test would be more robust in this case. 
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However, an explicit study involving non-normal real and/or simulated data would be 
needed to test this hypothesis. 
In our study design we ignored design factors which could cause dependencies 
between samples from the same phenotypic group (diseased / control). This may have 
an impact on the results, and in particular a sampling design which accounts for the 
design factors in the study may be more appropriate. Additionally, using a more 
complicated model for the gene expression values, which includes the original design 
variables in the model, would be worthwhile to investigate. In this case, a 
comparison between the standard linear model and the hierarchical empirical 
Bayesian model (Smyth 2004) would be warranted. In subsequent research, we will 
check the experimental design for each data set, to determine whether this should be 
accounted for when taking subsamples from the data. 
In our paper, we randomly chose subsets from the full data set and evaluated 
consistency between the DE detection methods using fixed list lengths. The smallest 
subset size we used was 6 (3 in each group), and sample sizes this small will have 
correspondingly low power to detect DE genes. Since we used fixed list lengths when 
evaluating the consistency for each method, our scores will only reflect the 
consistency based on the test statistic itself, and ignores the ability of each method to 
retain power when the sample size is small. Subsequent studies which compare lists 
based on a significance threshold would be needed to test whether any differences 
between the methods existed on this account. 
Lastly, in our research we evaluated the consistency of the DE detection 
methods using only real data. To supplement these experiments, it would be 
interesting to use simulation methods (Parrish 2009) to create simulated data which 
reflect the real microarray data but with a larger number of samples. This would 
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enable us to better detennine a 'true' list of DE genes, and to better map the rate of 
convergence between the methods as the sample size increases. 
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POG score for Colon Cancer 
Method subsetllength 50 100 500 1000 
T-test 6 0.140 0.170 0.380 0.560 
10 0.270 0.298 0.489 0.627 
20 0.502 0.524 0.663 0.729 
50 0.761 0.784 0.841 0.860 
Empirical Bayes 6 0.175 0.223 0.416 0.574 
10 0.299 0.318 0.507 0.635 
20 0.518 0.540 0.668 0.731 
50 0.770 0.790 0.844 0.861 
SAM 6 0.179 0.234 0.420 0.577 
10 0.301 0.332 0.515 0.637 
20 0.538 0.568 0.677 0.736 
50 0.793 0.797 0.847 0.865 
Table 1 
POGR score for Colon Cancer 
Method subsetllength SO 100 500 1000 
T-test 6 0.410 0.512 0.807 0.907 
10 0.518 0.633 0.882 0.935 
20 0.796 0.829 0.930 0.956 
SO 0.934 0.944 0.973 0.978 
Empirical Bayes 6 0.482 0.599 0.832 0.916 
10 0.578 0.659 0.890 0.936 
20 0.810 0.841 0.931 0.955 
50 0.939 0.952 0.973 0.978 
SAM 6 0.495 0.602 0.833 0.914 
10 0.597 0.670 0.892 0.935 
20 0.832 0.858 0.933 0.954 
SO 0.958 0.949 0.973 0.977 
Table 2 
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nPOG score for Colon Cancer 
Method subset/length 50 100 500 1000 
T-test 6 0.118 0.124 0.170 0.121 
10 0.249 0.261 0.319 0.255 
20 0.489 0.499 0.551 0.457 
50 0.755 0.772 0.787 0.720 
Empirical Bayes 6 0.154 0.181 0.218 0.149 
10 0.280 0.282 0.343 0.270 
20 0.505 0.516 0.558 0.462 
50 0.765 0.778 0.790 0.723 
SAM 6 0.158 0.192 0.224 0.154 
10 0.282 0.296 0.354 0.274 
20 0.525 0.546 0.569 0.473 
50 0.788 0.786 0.795 0.729 
Table 3 
nPOGR score for Colon Cancer 
Method subset/length 50 100 500 1000 
T-test 6 0 0 0 0 
10 0 0 0.074 0 
20 0.560 0.496 0.437 0.232 
50 0.859 0.836 0.782 0.614 
Empirical Bayes 6 0 0 0 0 
10 0.103 0 0.130 0 
20 0.589 0.531 0.446 0.228 
50 0.871 0.859 0.787 0.612 
SAM 6 0 0 0 0 
10 0.144 0.021 0.146 0 
20 0.638 0.583 0.462 0.211 
50 0.910 0.851 0.781 0.596 
Table 4 
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POG score for Lung Expression 
Method subsetJIength 50 100 500 1000 
T-test 6 0.064 0.079 0.209 0.346 
10 0.099 0.127 0.253 0.378 
20 0.182 0.204 0.311 0.416 
50 0.341 0.364 0.455 0.519 
Empirical Bayes 6 0.088 0.105 0.220 0.352 
10 0.130 0.156 0.261 0.382 
20 0.202 0.218 0.315 0.417 
50 0.351 0.374 0.456 0.518 
SAM 6 0.102 0.123 0.237 0.367 
10 0.151 0.180 0.273 0.393 
20 0.232 0.254 0.336 0.427 
50 0.377 0.388 0.462 0.528 
Table 5 
POGR score for Lung Expression 
Method subsetJIength 50 100 500 1000 
T-test 6 0.065 0.080 0.258 0.443 
10 0.100 0.128 0.302 0.475 
20 0.183 0.206 0.346 0.499 
50 0.343 0.368 0.487 0.593 
Empirical Bayes 6 0.090 0.108 0.272 0.450 
10 0.132 0.158 0.311 0.481 
20 0.204 0.221 0.353 0.505 
50 0.353 0.381 0.489 0.594 
SAM 6 0.104 0.132 0.304 0.474 
10 0.154 0.188 0.337 0.502 
20 0.234 0.260 0.391 0.530 
50 0.379 0.398 0.510 0.614 
Table 6 
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nPOG score for Lung Expression 
Method subsetJIength 50 100 500 1000 
T-test 6 0.050 0.050 0.059 0.043 
10 0.086 0.099 0.115 0.093 
20 0.166 0.178 0.182 0.147 
50 0.330 0.343 0.354 0.299 
Empirical Bayes 6 0.074 0.077 0.073 . 0.052 
10 0.118 0.129 0.125 0.098 
20 0.187 0.192 0.187 0.149 
50 0.341 0.353 0.355 0.297 
SAM 6 0.089 0.095 0.093 0.074 
10 0.139 0.154 0.139 0.115 
20 0.218 0.229 0.211 0.164 
50 0.367 0.367 0.361 0.311 
Table 7 
nPOGR score for Lung Expression 
Method subsetJIength 50 100 500 1000 
T-test 6 0 0 0 0 
10 0.036 0.016 0 0 
20 0.122 0.097 0.020 0.006 
50 0.294 0.284 0.228 0.190 
Empirical Bayes 6 0.023 0 0 0 
10 0.070 0.050 0 0 
20 0.144 0.114 0.031 0.017 
50 0.305 0.299 0.231 0.192 
SAM 6 0.038 0.017 0 0 
10 0.093 0.084 0.004 0.011 
20 0.176 0.159 0.088 0.066 




POG score for Leukimia 
Method subsetJIength 50 100 500 1000 
T-test 6 0.177 0.204 0.340 0.485 
10 0.280 0.340 0.456 0.547 
20 0.582 0;591 0.662 0.718 
50 0.750 0.784 0.817 0.844 
Empirical Bayes 6 0.246 0.272 0.378 0.497 
10 0.328 0.378 0.470 0.552 
20 0.602 0.608 0.667 0.721 
50 0.759 0.791 0.818 0.845 
SAM 6 0.266 0.294 0.408 0.511 
10 0.366 0.404 0.487 0.556 
20 0.657 0.672 0.698 0.729 
50 0.823 0.833 0.839 0.850 
Table 9 
POGR score for Leukimia 
Method subsetJIength 50 100 500 1000 
T-test 6 0.549 0.552 0.650 0.737 
10 0.657 0.684 0.712 0.768 
20 0.834 0.816 0.821 0.845 
50 0.917 0.909 0.906 0.921 
Empirical Bayes 6 0.632 0.616 0.677 0.746 
10 0.706 0.711 0.720 0.771 
20 0.843 0.836 0.824 0.846 
50 0.921 0.917 0.906 0.921 
SAM 6 0.623 0.652 0.706 0.761 
10 0.708 0.749 0.746 0.783 
20 0.831 0.896 0.853 0.856 
50 0.914 0.954 0.927 0.927 
Table 10 
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nPOG score for Leukimia 
Method subsetJIength 50 100 500 1000 
T-test 6 0.160 0.172 0.190 0.182 
10 0.265 0.312 0.330 0.281 
20 0.574 0.576 0.585 0.552 
50 0.745 0.776 0.775 0.753 
Empirical Bayes 6 0.231 0.242 0.237 0.202 
10 0.314 0.352 0.348 0.289 
20 0.593 0.593 0.592 0.556 
50 0.755 0.783 0.777 0.755 
SAM 6 0.250 0.266 0.273 0.223 
10 0.353 0.380 0.369 0.295 
20 0.650 0.659 0.629 0.568 
50 0.820 0.826 0.803 0.762 
Table 11 
nPOGR score for Leukimia 
Method subsetJIength 50 100 500 1000 
T-test 6 0.486 0.441 0.352 0.287 
10 0.612 0.610 0.466 0.372 
20 0.812 0.773 0.667 0.579 
50 0.906 0.886 0.825 0.786 
Empirical Bayes 6 0.581 0.522 0.403 0.313 
10 0.668 0.644 0.481 0.380 
20 0.823 0.797 0.672 0.581 
50 0.910 0.896 0.825 0.785 
SAM 6 0.571 0.567 0.455 0.354 
10 0.670 0.690 0.530 0.412 
20 0.809 0.871 0.727 0.608 
50 0.902 0.943 0.863 0.803 
Table 12 
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nPOG score for lung Cancer 
Method subset/length 50 100 500 1000 
T-test 4 0.083 0.110 0.204 0.179 
8 0.094 0.122 0.201 0.190 
12 0.112 0.159 0.266 0.242 
16 0.130 0.193 0.303 0.271 
Empirical Bayes 4 0.166 0.209 0.255 0.191 
8 0.167 0.209 0.256 0.201 
12 0.177 0.231 0.299 0.251 
16 0.188 0.248 0.321 0.284 
SAM 4 0.166 0.218 0.261 0.194 
8 0.166 0.221 0.263 0.204 
12 0.183 0.247 0.308 0.254 
16 0.202 0.270 0.330 0.290 
Table 13 
nPOGR 0.75 score for Lung Cancer 
From eDNA to Affymetrix From Affymetrix to eDNA 
Method subset/length 50 100 500 1000 50 100 500 1000 
T-test 4 0.172 0.041 0.033 0.009 0.191 0.081 0.042 0.010 
8 0.212 0.054 0.047 0.012 0.232 0.094 0.050 0.019 
12 0.311 0.153 0.058 0.034 0.321 0.173 0.058 0.041 
16 0.377 0.214 0.107 0.086 0.365 0.218 0.107 0.092 
Empirical 4 0.465 0.416 0.267 0.178 0.342 0.340 0.272 0.190 
Bayes 8 0.472 0.429 0.265 0.188 0.354 0.353 0.272 0.198 
12 0.512 0.457 0.304 0.237 0.406 0.386 0.318 0.248 
16 0.550 0.477 0.325 0.271 0.401 0.409 0.340 0.283 
SAM 4 0.468 0.436 0.272 0.181 0.345 0.353 0.278 0.191 
8 0.466 0.435 0.271 0.190 0.361 0.367 0.278 0.200 
12 0.519 0.475 0.312 0.240 0.396 0.388 0.325 0.250 
16 0.538 0.487 0.332 0.277 0.389 0.412 0.348 0.288 
Table 14 
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nPOG score for DMD 
Method subset/length 50 100 500 1000 
T-test 6 0.061 0.085 0.163 0.165 
12 0.190 0.246 0.327 0.296 
18 0.256 0.333 0.404 0.376 
24 0.296 0.429 0.455 0.422 
Empirical Bayes 6 0.242 0.261 0.278 0.221 
12 0.297 0.348 0.375 0.319 
18 0.319 0.410 0.432 0.394 
24 0.377 0.496 0.485 0.431 
SAM 6 0.233 0.247 0.265 0.214 
12 0.306 0.346 0.372 0.318 
18 0.336 0.418 0.432 0.395 
24 0.383 0.492 0.485 0.436 
Table 15 
nPOGR 0.75 score for DMD Cancer 
From Haslett to Pescatori From Pescatori to Haslett 
Method subset/length 50 100 500 1000 50 100 500 1000 
T-test 6 0.178 0.169 0.147 0.138 0.185 0.174 0.141 0.138 
12 0.247 0.232 0.143 0.117 0.263 0.222 0.163 0.117 
18 0.383 0.188 o 181 0.099 0.397 0.268 0.221 0.129 
24 0.377 0.299 0.216 0.159 0.407 0.312 0.245 0.174 
Empirical 6 0.601 0.598 0.422 0.267 0.636 0.604 0.423 0.276 
Bayes 12 0.688 0.678 0.469 0.344 0.736 0.691 0.487 0.344 
18 0.714 0.711 0.504 0.409 0.783 0.740 0.531 0.399 
24 0.725 0.749 0.530 0.437 0.803 0.775 0.570 0.435 
SAM 6 0.591 0.586 0.406 0.261 0.614 0.582 0.405 0.262 
12 0.687 0.674 0.466 0.345 0.730 0.681 0.479 0.340 
18 0.717 0.707 0.506 0.409 0.774 0.743 0.530 0.402 
24 0.697 0.747 0.529 0.440 0.812 0.793 0.571 0.442 
Table 16 
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R code for 3.1 
ALL data 







## I. Get ALL data, compare BRC/ ABL with NEG for mol.biol 
data(ALL) 
subset <- intersect(which(ALL$mol.biol%in%c("BCRI ABL", "NEG"», 
grep("/\B", as.character(ALL$BT))) 
## selects 79 samples 
a1l2 <- ALL[ ,subset] #Note: ALL data is log2 transformed 
## table(pData(a1l2)$mol.biol) 
## ALLl/AF4 BCRlABL E2A1PBXI 





filt.a1l2 <- nsFilter( a1l2, require.entrez=F ALSE, 
require.GOBP=F ALSE, remove.dupEntrez=TRUE, 
feature.exclude="/\AFFX", var.cutoff=0.5) 




## 4399 79 
a1l2<-filt.a1l2 
pData(a1l2)$mol.biol <- factor(pData(a1l2)$mol.biol) 
## 2. Calculate and store p-values for FULL data 
## 2A. eBayes using limma 
## Design drops the column vector of ones 
design <- model.matrix( ~mol.biol - 1, data = a1l2) 
colnames(design) <- c("BCR_ABL", "NEG") 
contr <- makeContrasts(BCR_ABL - NEG, levels=design) 
## now fit eBayes model using ImFit 
fitl <- ImFit(a1l2, design) 
fitc <- contrasts.fit(fitl, contr) 
fitc <- eBayes(fitc) 
## get top 1000 genes based on p-values 
res.ebayes.all <- topTable(fitc, adjust.method="BH", number=1 0000 
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## 2B. T-tests 
tt <- rowttests(a1l2, "mol.biol") 
ttest.all <- tt[order(tt$p.value),] 
## 2C. SAM 
data <- list(x = exprs(a1l2), y = pData(a1l2)$mol.biol, 
geneid = featureNames( all2), genenames=featureNames( a1l2), 
logged2=TRUE) 
res.sam <- samr(data = data, resp.type="Two class unpaired",nperms=10) 
## 3. Take top 1000 genes from each method 
## 3a.eBayes 
res.ebayes.all <- topTable(fitc, adjust.method="BH", number=1000) 
head(res.ebayes.all) 
## 3b. T-tests 
ttest.all<-head(tt[ order(tt$p. value ),],n= 1000) 
## 3c. SAM 
sam. top 1 000 <- sort( abs( res.sam$tt), decreasing=TRUE)[ 1: 1 000] 
########################################################################### 
## Calculate the expectation value of ALL data. 
########################################################################### 
## Run at least 100 
nsim <- 100 
n.subsample <- c(6, 10,20,50) 
k.size <- c(50, 100, 500, 1000) 
pog.E <- array(NA, dim=c(4, 4, nsim), 
dimnames = list(n.subsample, k.size, 1 :nsim)) 
pogr.E <- array(NA, dim=c(4, 4, nsim), 
dimnames = list(n.subsample, k.size, 1 :nsim)) 
pogr.E.0.8 <- array(NA, dim=c(4, 4, nsim), 
dimnames = list(n.subsample, k.size, 1 :nsim)) 
source("pogr.R") 
for (i in 1:4) { ## size of subset 
for G in 1 :nsim) { 
set. seed( (i * 1 00+j)) 
subsetBCRnABL <- intersect(which(a1l2$mol.biol%in%c("BCRlABL")), 
grep( II "B ", as .character(ALL$BT))) 
subsetNEG <- intersect( which( a1l2$mol. biol%in%c("NEG")), 
grep("I\B", as.character( ALL$BT)) 
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## For subsets 1 
sub.idxBCRnABL 1 <- sample(subsetBCRnABL, n.subsample[i]!2, replace=FALSE) 
sub.idxNEG 1 <- sample(subsetNEG, n.subsample[i]/2, replace=FALSE) 
sub.idx 1 <- union(sub.idxBCRnABL 1 ,sub.idxNEG 1 ) 
sub.mol.bioll <- pData( a1l2)$mol.biol[ sub.idx 1] 
all sub 1 <- all 2 [,sub.idx 1] 
## 1. Randomly pick two lists (size 1000) 
## head( exprs( all sub 1» 
idx 1 <- sample{l :nrow( all sub 1), 1000, replace=F ALSE) 
idx2 <- sample( 1 :nrow( a1l2), 1000, replace=F ALSE) 
I istl <- rownames( exprs( all sub 1) )[idx 1] 
list2 <- rownames(exprs(a1l2»[idx2] 
## Check overlap with original gene list in terms of ranking for top 1000 
## First, simple E[POG] score 
pog.E[i,4, j] <- length(intersect(listl [1: 1 000], list2[1: 1000]))/1000 
pog.E[i,3, j] <- length(intersect(listl [1 :500], list2[1 :500]))/500 
pog.E[i,2, j] <- length(intersect(listl [1: 100], list2[1: 1 00]))/1 00 
pog.E[i,l, j] <- length(intersect(listl [1 :50], list2[ 1 :50]))/50 
all.genes <- union(listl, list2) 
cor.all.genes <- cor(t(exprs(a1l2)[all.genes, ])) 
diag( cor.all.genes) <- 0 
pogr.E[i, 4, j] <- pogr( cor.all.genes, list1 [1: 1 000], list2[1: 1000],0.5) 
pogr.E[i, 3, j] <- pogr( cor.all.genes, list1 [1 :500], list2[1 :500], 0.5) 
pogr.E[i, 2, j] <- pogr( cor.a1I.genes, 1ist1 [1: 1 00], list2[1: 1 00], 0.5) 
pogr.E[i, 1, j] <- pogr( cor.all.genes, listl [1 :50], list2[1 :50], 0.5) 
pogr.E.O.S[i, 4, j] <- pogr( cor.a1I.genes, list 1 [1: 1 000], 1ist2[1: 1 000], O.S) 
pogr.E.O.S[i, 3, j] <- pogr( cor.all.genes, listl [1 :500], list2[1 :500], O.S) 
pogr.E.O.S[i, 2, j] <- pogr( cor.all.genes, list! [1: 100], list2[1: 100], O.S) 
pogr.E.O.S[i, 1, j] <- pogr( cor.all.genes, list! [1 :50], list2[ 1 :50], O.S) 
}} 
## cutoff=0.5 
exp.POG <- ftable(apply(pog.E, c(1,2), mean» ## saved as a matrix 
exp.POGR <- ftable(apply(pogr.E, c(1,2), mean» 
## cutoff=O.S 
exp.POGR.O.S <- ftable(apply(pogr.E.O.S, c(1,2), mean» 
##write.csv( ) 
write.csv(exp.POG,file=IE(pog).csv",row.names =FALSE) 
write.csv( exp.POGR,file="E(pogr).csv",row.names =F ALSE) 
## cutoff=O.S 
write.csv( exp.POGR.O.S,file=IE(pogr)OS.csv" ,row.names =F ALSE) 
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##read.csv 
EPOG <- read.csv("E(pog).csv") 
EPOGR <- read.csv("E(pogr).csv") 
## cutoff=0.8 
EPOGR.0.8 <- read.csv("E(pogr)08.csv") 
########################################################################### 
## Calculate the scores of DEGs 
########################################################################### 
nsim <- 25 
n.subsample <- c(6, 10,20,50) 
k.size <- c(50, 100, 500, 1000) 
## Create array to store results (what are they?) 
pog.array <- array(NA, dim=c(3, 4, 4, nsim), 
dimnames = list(c("ebayes", "ttest", "SAM"), n.subsample, k.size, 1 :nsim)) 
pogr.array <- array(NA, dim=c(3, 4, 4, nsim), 
dimnames = Iist(c("ebayes", "ttest", "SAM"), n.subsample, k.size, l:nsim)) 
npog.array <- array(NA, dim=c(3, 4, 4, nsim), 
dimnames = list(c("ebayes", "ttest", "SAM"), n.subsample, k.size, 1 :nsim)) 
npogr.array <- array(NA, dim=c(3, 4, 4, nsim), 
dimnames = Iist(c("ebayes", "ttest", "SAM"), n.subsample, k.size, 1 :nsim)) 
pogr.array.0.8 <- array(NA, dim=c(3, 4, 4, nsim), 
dimnames = list(c("ebayes", "ttest", "SAM"), n.subsample, k.size, 1 :nsim)) 
npogr.array.0.8 <- array(NA, dim=c(3, 4, 4, nsim), 
dimnames = list(c("ebayes", "ttest", "SAM"), n.subsample, k.size, l:nsim)) 
## To calculate normalized scores 
EPOG <- read.csv("E(pog).csv") 
EPOGR <- read.csv("E(pogr).csv") 
## cutoff=0.8 
EPOGR.0.8 <- read.csv("E(pogr)OS.csv") 
## do the same for POGR array and any other results 
## need loops over size of subsample and # simulations 
## other factors will be 'inside' of looops 
## source code for POGR score 
source("pogr.R") 
for(i in 1:4) { 
for G in 1 :nsim) { 
## set seed for each simulation so results are exactly reproducible 
set.seed((i* 1 OO+j)) 
## 1. size of subsample 
subset <- intersect(which(ALL$mol.biol%in%c("BCR! ABL", "NEG")), 
grep(""B", as.character(ALL$BT))) 
## selects 79 samples 
subsetBCRnABL <- intersect(which( a1l2$mol.biol%in%c("BCR! ABL ")), 
grep("'\B", as.character(ALL$BT))) 
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subsetNEG <- intersect( which( all2$mol. biol%in%c("NEG"», 
grep(""'B", as.character(ALL$BT») 
sub.idxBCRnABL <- sample(subsetBCRnABL, n.subsample[i]!2, replace=FALSE) 
sub.idxNEG <- sample(subsetNEG, n.subsample[i]!2, replace=FALSE) 
sub.idx<- union(sub.idxBCRnABL,sub.idxNEG ) 
sub.mol.biol <- pData(aIl2)$mol.biol[sub.idx] 
allsub <- a1l2[,sub.idx] 
########################################################################### 
## 2A. E-BA YES (LIMMA) METHOD 
########################################################################### 
Inames(design) <- c("BCR_ABL", "NEG") 
contr <- makeContrasts(BCR _ABL - NEG, levels=design) 
fitlsub <- ImFit(a1l2[,sub.idx], design) 
fitcsub <- contrasts.fit(fitlsub, contr) 
fitcsub <- eBayes( fitcsub) 
## Full gene list 
res.ebayes.all <- topTable(fitc, adjust.method="BH", number=IOOO) 
res sub <- topTable( fitcsub, adjust.method="BH", number= 1000) 
pog.array["ebayes" ,i, 4, j] <- length(intersect(ressub$ID[ I: 1 000], 
res.ebayes.all$ID[I: 1 000]))/1 000 
pog.array["ebayes",i, 3, j] <- length(intersect(ressub$ID[1 :500], 
res.ebayes.all$ID[1 :500]))/500 
pog.array["ebayes",i, 2, j] <- length(intersect(ressub$ID[I: 1 00], 
res.ebayes.all$ID[ I: 100]))/1 00 
pog.array["ebayes",i, I, j] <- length(intersect(ressub$ID[1 :50], res.ebayes.all$ID[1 :50]))/50 
## Normalized POG 
npog.array["ebayes",i, 4, j] <- (pog.array["ebayes",i, 4, j] - EPOG[i,4])/(I-EPOG[i,4]) 
npog.array["ebayes",i, 3,j] <- (pog.array["ebayes",i, 3,j] - EPOG[i,3])/(1-EPOG[i,3]) 
npog.array["ebayes" ,i, 2, j] <- (pog.array["ebayes" ,i, 2, j] - EPOG[i,2])/( I-EPOG[i,2]) 
npog.array["ebayes" ,i, I, j] <- (pog.array["ebayes" ,i, I, j] - EPOG[i, I ])/(1-EPOG[i, I]) 
## Now, look at POGR score 
all.genes <- union(ressub$ID, res,ebayes.all$ID) 
cor.all.genes <- cor(t( exprs( aIl2)[ all.genes, ])) 
diag( cor.all.genes) <- 0 
## cutoff=0.5 
pogr.array["ebayes" ,i, 4, j] <- pogr( cor.all.genes, res.ebayes.all$ID[ I: 1 000], 
ressub$ID[ I: 1 000], 0.5) 
pogr.array["ebayes" ,i, 3, j] <- pogr( cor.all.genes, res.ebayes.all$ID[ 1 :500], ressub$ID[ 1 :500], 
0.5) 
pogr.array["ebayes",i, 2, jl <- pogr( cor.all.genes, res.ebayes.all$ID[I: 1 00], ressub$ID[I: 1 00], 
0.5) 
pogr.array["ebayes" ,i, I, j] <- pogr( cor.all.genes, res.ebayes.all$ID[1 :50], ressub$ID[l :50], 
0.5) 
npogr.array["ebayes" ,i, 4, j] <- (pogr.array["ebayes" ,i, 4, j] - EPOGR[i,4 ])/(1-EPOGR[i,4]) 
npogr.array["ebayes",i, 3,j] <- (pogr.array["ebayes",i, 3,j] - EPOGR[i,3])/(1-EPOGR[i,3]) 
npogr.array["ebayes" ,i, 2, j] <- (pogr.array["ebayes" ,i, 2, j] - EPOGR[i,2])/( I-EPOGR[i,2]) 
npogr.array["ebayes",i, I, j] <- (pogr.array["ebayes",i, I, j] - EPOGR[i,1 ])/(1-EPOGR[i, 1]) 
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## cutoff=0.8 
pogr.array.0.8["ebayes" ,i, 4, j] <- pogr( cor.all.genes, res.ebayes.all$ID[I: 1000], 
ressub$ID[ 1: 1 000], 0.8) 
pogr.array.0.8["ebayes" ,i, 3, j] <- pogr( cor.all.genes, res.ebayes.all$ID[1 :500], 
ressub$ID[ 1 :500],0.8) 
pogr.array.0.8["ebayes",i, 2, j] <- pogr( cor.all.genes, res.ebayes.all$ID[I: 1 00], 
ressub$ID[ I: I 00],0.8) 
pogr.array.0.8["ebayes",i, I, j] <- pogr( cor.all.genes, res.ebayes.all$ID[1 :50], ressub$ID[1 :50], 
0.8) 
npogr.array.0.8["ebayes",i, 4, j] <- (pogr.array.0.8["ebayes",i, 4, j] -
EPOGR.0.8[i,4 ])/( I-EPOGR.0.8[i,4]) 
npogr.array.0.8["ebayes",i, 3,j] <- (pogr.array.0.8["ebayes",i, 3,j]-
EPOGR.0.8[i,3])/( l-EPOGR.0.8[i,3]) 
npogr.array.0.8["ebayes",i, 2, j] <- (pogr.array.0.8["ebayes",i, 2, j] -
EPOGR.0.8 [i,2])/( 1-EPOGR.O. 8 [i,2]) 





ttsub <- rowttests( all2[,sub.idx], a1l2[,sub.idx ]$mol.biol) 
ttest.sub<-head(ttsub[ order(ttsub$p. value ),],n= 1 000) 
ttest.all<-head(tt[ order(tt$p. value ),],n= 1 000) 
## First, simple POG score 
rownames(ttest.all) 
rownames(ttest.sub) 
pog.array["ttest",i, 4, j] <- length(intersect(rownames(ttest.all)[I: 1000], 
rownames(ttest.sub)[I: 1000]))11000 
pog.array["ttest",i, 3, j] <- length(intersect(rownames(ttest.all)[1 :500], 
rownames(ttest.sub)[ 1 :500]))/500 
pog.array["ttest" ,i, 2, j] <- length(intersect( rownames( ttest.all)[ I : 100], 
rownames(ttest.sub )[1: 1 00]))11 00 
pog.array["ttest" ,i, I, j] <- length(intersect(rownames(ttest.all)[ 1:50], 
rownames(ttest.sub )[1 :50]))/50 
## Normalized POG 
npog.array["ttest",i, 4,j] <- (pog.array["ttest",i, 4,j] - EPOG[i,4])/(l-EPOG[i,4]) 
npog.array["ttest" ,i, 3, j] <- (pog.array["ttest",i, 3, j] - EPOG[i,3])/(l-EPOG[i,3]) 
npog.array["ttest",i, 2, j] <- (pog.array["ttest",i, 2, j] - EPOG[i,2])/(l-EPOG[i,2]) 
npog.array["ttest" ,i, I, j] <- (pog.array["ttest",i, 1, j] - EPOG[i, I ])/(l-EPOG[i, I]) 
## Now, look at POGR score 
all.genes <- union( rownames( ttest.all), rownames( ttest.sub)) 
cor.all.genes <- cor(t(exprs(all2)[all.genes,])) 
## need to find which are significant Gust pick a cut-off (say 0.5) and use that) 
## need to look at all OFF DIAGONAL values of cor.all.genes (set diagonal values to zero) 
diag( cor.all.genes) <- 0 
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## maybe have another dimension for correlation cutoff?? (0.5, 0.8) 
## cutoff=0.5 
pogr.array["ttest" ,i, 4, j] <- pogr( cor.all.genes, rownames(ttest.all)[ 1: 1000], 
rownames(ttest.sub)[ 1: 1 000], 0.5) 
pogr.array["ttest",i, 3, j] <- pogr( cor.all.genes, rownames(ttest.all)[l :500], 
rownames(ttest.sub)[ 1 :500], 0.5) 
pogr.array["ttest" ,i, 2, j] <- pogr( cor.all.genes, rownames(ttest.all)[ 1: 100], 
rownames(ttest.sub )[1: 100], 0.5) 
pogr.array["ttest",i, 1, j] <- pogr( cor.all.genes, rownames(ttest.all)(1 :50], 
rownames(ttest.sub)(1 :50],0.5) 
npogr.array["ttest" ,i, 4, j] <- (pogr.array["ttest" ,i, 4, j] - EPOGR[i,4 ))/(1-EPOGR[i,4)) 
npogr.array["ttest",i, 3,j] <- (pogr.array["ttest",i, 3,j] - EPOGR[i,3))/(I-EPOGR[i,3)) 
npogr.array["ttest",i, 2, j] <- (pogr.array["ttest",i, 2, j] - EPOGR[i,2))/(1-EPOGR[i,2)) 
npogr.array["ttest",i, l,j] <- (pogr.array["ttest",i, l,j] - EPOGR[i,I))/(1-EPOGR[i,l)) 
## cutoff=0.8 
pogr.array.0.8["ttest",i, 4, j] <- pogr(cor.all.genes, rownames(ttest.all)[I: 1 000], 
rownames(ttest.sub)[ 1: 1000], 0.8) 
pogr.array.0.8["ttest" ,i, 3, j] <- pogr( cor.all.genes, rownames(ttest.all)[1 :500], 
rownames(ttest.sub)[ 1 :500], 0.8) 
pogr.array.0.8["ttest",i, 2, j] <- pogr( cor.all.genes, rownames(ttest.all)(1: 1 00], 
rownames(ttest.sub )[1: 1 00], 0.8) 
pogr.array.0.8["ttest",i, 1, j] <- pogr( cor.all.genes, rownames(ttest.all)[1 :50], 
rownames(ttest.sub)[1 :50],0.8) 
npogr.array.0.8["ttest",i, 4, j] <- (pogr.array.0.8["ttest",i, 4, j] -
EPOGR.0.8[i,4 ))/( l-EPOGR.0.8[i,4)) 
npogr.array.0.8["ttest",i, 3, j] <- (pogr.array.0.8["ttest",i, 3, j] -
EPOGR.0.8[i,3))/( l-EPOGR.0.8[i,3)) 
npogr.array.0.8["ttest",i, 2, j] <- (pogr.array.0.8["ttest",i, 2, j] -
EPOGR.0.8[i,2))/( l-EPOGR.0.8[i,2)) 
npogr.array.0.8["ttest",i, l,j] <- (pogr.array.0.8["ttest",i, l,j]-
EPOGR.0.8[i, 1 ))/( l-EPOGR.0.8[i, 1]) 
########################################################################### 
## 2e. SAM 
########################################################################### 
data <- list(x = exprs(a1l2[,sub.idx)), y = pData(a1l2[,sub.idx))$mol.biol, 
geneid = featureNames(a1l2[,sub.idx)), 
genenames=featureNames(a1l2[,sub.idx)), 
logged2=TRVE) 
samsub <- samr(data = data, resp.type="Two class unpaired", nperms=10) 
samsub. top 1000 <- sort( abs( samsub$tt), decreasing=TR VE) [ 1 : 1 000] 
## First, simple POG score 
pog.array["SAM",i, 4, j] <- length(intersect(names(sam.topl000)[1 :1000], 
names(samsub.top 1 000)[1:1000]))/1 000 
pog.array["SAM" ,i, 3, j] < - length(intersect(names(sam.topl 000)[ 1 :500], 
names(samsub.top 1 000)(1 :500]))/500 
pog.array["SAM",i, 2, j] <- length(intersect(names(sam.topl000)[1 :100], 
names( samsub. top 1 000)[ 1 : 1 00]))/1 00 
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pog.array["SAM" ,i, 1, j] <- length(intersect(names(sam.top 1 000)[ 1 :50], 
names(samsub.top 1000)[ 1 :50]))/50 
## Normalized POG 
npog.array["SAM",i, 4, j] <- (pog.array["SAM",i, 4, j] - EPOG[i,4])/(l-EPOG[i,4]) 
npog.array["SAM",i, 3, j] <- (pog.array["SAM",i, 3, j] - EPOG[i,3])/(1-EPOG[i,3]) 
npog.array["SAM",i, 2, j] <- (pog.array["SAM",i, 2, j] - EPOG[i,2])/(l-EPOG[i,2]) 
npog.array["SAM",i, 1,j] <- (pog.array["SAM",i, l,j] - EPOG[i,I])/(l-EPOG[i,1]) 
## Now, look at POGR score 
all. genes <- union(names(samsub.topl000), names(sam.top1000)) 
cor.all.genes <- cor(t( exprs( a1l2)[ all.genes, ])) 
diag(cor.all.genes) <- 0 
## cut point=0.5 
pogr.array["SAM" ,i, 4, j] <- pogr( cor.all.genes, names(sam.top 1 000)[ 1: 1 000], 
names(samsub.top1000)[1 :1000],0.5) 
pogr.array["SAM" ,i, 3, j] <- pogr( cor.all.genes, names(sam.top 1000)[ 1 :500], 
names(samsub.top 1 000)[1 :500],0.5) 
pogr.array["SAM" ,i, 2, j] <- pogr( cor.all.genes, names(sam.top 1000)[ 1: 1 00], 
names(samsub.top1000)[1 :100],0.5) 
pogr.array["SAM",i, l,j] <- pogr(cor.all.genes, names(sam.top1000)[1:50], 
names(samsub.top 1 000)[ 1 :50], 0.5) 
npogr.array["SAM",i, 4,j] <- (pogr.array["SAM",i, 4,j] - EPOGR[i,4])/(l-EPOGR[i,4]) 
npogr.array["SAM",i, 3,j] <- (pogr.array["SAM",i, 3,j] - EPOGR[i,3])/(I-EPOGR[i,3]) 
npogr.array["SAM",i, 2,j] <- (pogr.array["SAM",i, 2,j] - EPOGR[i,2])/(l-EPOGR[i,2]) 
npogr.array["SAM",i, 1,j] <- (pogr.array["SAM",i, 1,j] - EPOGR[i,1])/(l-EPOGR[i,l]) 
## cutoff=0.8 
pogr.array.0.8["SAM",i, 4,j] <- pogr(cor.all.genes, names(sam.top1000)[1:1000], 
names(samsub.top1000)[1 :1000],0.8) 
pogr.array.0.8["SAM",i, 3,j] <- pogr(cor.all.genes, names(sam.top1000)[1:500], 
names(samsub.top1000)[1 :500],0.8) 
pogr.array.0.8["SAM" ,i, 2, j] <- pogr( cor.all.genes, names(sam.top1 000)[1: 1 00], 
names(samsub.topl 000)[1 :100],0.8) 
pogr.array.0.8["SAM" ,i, 1, j] <- pogr( cor.all.genes, names(sam.top 1 000)[ 1 :50], 
names(samsub.top 1000)[1 :50], 0.8) 
npogr.array.0.8["SAM",i, 4,j] <- (pogr.array.0.8["SAM",i, 4,j]-
EPOGR.0.8[i,4 ])/( 1-EPOGR.0.8[i,4]) 
npogr.array.0.8["SAM",i, 3,j] <- (pogr.array.0.8["SAM",i, 3,j]-
EPOGR.0.8[i,3])/(I-EPOGR.0.8[i,3]) 
npogr.array.0.8["SAM",i, 2, j] <- (pogr.array.0.8["SAM",i, 2, j] -
EPOGR.0.8 [i,2])/( 1-EPOGR.0.8[i,2]) 




## END OF SIMULA nON LOOPS 
########################################################################## 
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## Codes for Conlon Cancer, Lung Expression and Leukimia are similar to the ALL 
data. 
########################################################################## 
## Plot nPOG and nPOGR scores for four data sets 
########################################################################## 
library(lattice) 
nPOG.ALL <- read.csv("npog ALL.csv") 
nPOG.colonCA <- read.csv("npog colonCA.csv") 
nPOG.LungExpression <- read.csv("npog michigan.csv") 
nPOG.Leukemia <- read.csv("npog Golub_Merge.csv") 
## Plot all using lattice - xyplot 
npog.all.mean <- rowMeans(nPOG.ALL) 
npog.colon.mean <- rowMeans(nPOG.colonCA) 
npog.lung.mean <- rowMeans(nPOG.LungExpression) 
npog.luek.mean <- rowMeans(nPOG.Leukemia) 
plot.df <- data.frame(npog = c(npog.all.mean, npog.coion.mean, npog.lung.mean, 
## plot.df 
npog.luek.mean), 
data = rep(c("ALL", "ColonCA", "Lung", "Leukemia"), each=l2), 
subset = rep(c(6,10,20,50), 12), 
method = rep(rep(c("eBayes", "t-test", "SAM"), each=4), 4)) 
xypiot(npog~subset I data, groups = method, type="l", data=piot.df, 




nPOGR.ALL <- read.csv("npogr.csv") 
nPOGR.colonCA <- read.csv("npogr colonCA.csv") 
nPOGR.LungExpression <- read.csv("npogr michigan.csv") 
nPOGR.Leukemia <- read.csv("npogr Golub_Merge.csv") 
npogr.all.mean <- rowMeans(nPOGR.ALL) 
npogr.coion.mean <- rowMeans(nPOGR.colonCA) 
npogr.lung.mean <- rowMeans(nPOGR.LungExpression) 
npogr.luek.mean <- rowMeans(nPOGR.Leukemia) 
plot.df <- data.frame(npogr = c(npogr.all.mean, npogr.colon.mean, npogr.lung.mean, 
##plot.df 
npogr.luek.mean), 
data = rep(c("ALL", "ColonCA", "Lung", "Leukemia"), each=12), 
subset = rep(c( 6,10,20,50), 12), 
method = rep(rep(c("eBayes", "t-test", "SAM"), each=4), 4)) 
xypiot(npogr~subset I data, groups = method, type="l", data=plot.df, 
auto.key=list( columns=3,title="nPOGR score for detecting DEG lists from the same 
data set")) 
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R code for section 3.2 
Prostate Cancer 













## Prostate Cancer cDNA data from Lapointe 
########################################################################### 
setwd(lf/mntJfs2lhome/dOyang03/prostatecDNAIf ) 
files <- dir(pattem="*\\.xls$If) 
## read.SMD(files) 
prostate.cDNA <- read.maimages(files, source=lfsmdlf) 
prostate.eset <- normalizeWithinArrays(prostate.cDNA, method = Ifmedianlf ) 
## dim(prostate.eset) 
## 43008 86 
geneNames <- prostate.eset$genes[,31 
rownames(prostate.eset$M)<-geneN ames 
prostate.eset2 <-prostate.eset$M[ unique( rownames(prostate.eset$M»,] 
########################################################################### 
## prostate Cancer Affy data from Lapointe 
########################################################################### 
setwd(lf/mntJfs2/home/dOyang03/prostateAffylf) 
prostate.Affy <- ReadAffyO 
head(pData(prostate.Affy) ) 
dim( exprs(prostate.Affy» 
## 409600 102 
prostate.Affy.rma <- rma(prostate.Affy) 





dime filt. prostate.Affy .rma$eset) 
## Features Samples 
## 4399 102 
prostate.Affy.rma2 <- fiit.prostate.Affy.rma$eset 
prostate.Affy.ID <-
mget(featureNames(prostate.Affy.rma2),hgu95av2SYMBOL,ifnotfound=NA) 
featureNames(prostate.Affy.rma2) <- prostate.Affy.ID 
prostate.eDNA2 <- prostate.eset$M[! apply(prostate.eset$M, 1 ,funetion(y) any(is.na(y)) ),] 
## overlap genes 
overlap <- interseet(prostate.Affy.ID,rownames(prostate.eDNA2)) 
prostate.eDNA3 <- prostate.eDNA2[ whieh( rownames(prostate.eDNA2)%in%overlap ),] 
prostate.eDNA4<-prostate.eDNA3[unique(rownames(prostate.eDNA3)),] 
prostate.Affy.rma3 <-
prostate.A ffy .rma2[ whieh( featureNames(prostate.Affy .rma2)%in%overlap)] 
## 2B. eBayes using limma 
pdl <- data.frame(grp=e(rep(1,86))) 
pdl $grp[ e(2,4,8, 13, 17, 19,22,24,26,29,31,32,34,37,38, 
43,44,47,50,53,54,57,59,63,65,68,74,77,78,80,83,84)]<-2 
pdl$grp <- faetor(pdl$grp, labels=e("Tumor","Normal")) 
rownames(pdl) <- eolnames(prostate.eDNA3) 
design 1 <- model.matrix( ~grp - 1, data = pd 1 ) 
eolnames(designl) <- e("Tumor", "Normal") 
eontrl <- makeContrasts(Tumor-Normal, levels=designl) 
## prostate.Affy 
pd2 <- data.frame(grp=e(rep(1,50),rep(2,52))) 
pd2$grp <- faetor(pd2$grp, labels=e("N ormal", "Tumor")) 
rownames(pd2) <- rownames(pData(prostate.Affy.rma3)) 
pData(prostate.Affy.rma3) <- pd2 
phenoData(prostate.Affy.rma3) 
design2 <- model.matrix( ~grp - I, data = prostate.Affy.rma3) 
eolnames(design2) <- e("Tumor", "Normal") 
eontr2 <- makeContrasts(Tumor-Normal, levels=design2) 
## prostate.eDNA 
fit 1 <- ImFit(prostate.eDNA4, design I) 
fitel <- eontrasts.fit(fitl, eontrl) 
fite 1 <- eBayes( fite 1 ) 
res. prostate. eDNA <- topTable( fite I, adjust.method="BH" ,number=1 000) 
## prostate.Affy 
fit2 <- ImFit(prostate.Affy.rma3, design2) 
fite2 <- eontrasts.fit(fit2, eontr2) 
fite2 <- eBayes(fite2) 
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res.prostate.Affy <- topTable(fitc2, adjust.method="BH",number=lOOO) 
## 2A. T -tests 
ttl <- rowttests(prostate.cDNA4, fac=pdl$grp) 
## res.ttest <- rowttests(prostate.eset$M,fac=pdl$grp) 
ttest.prostate.cDNA <- ttl [order(ttl $p.value),] 
## prostate.Affy 
tt2 <- rowttests(prostate.Affy.rmaJ, "grp") 
ttest.prostate.Affy <- tt2[ order(tt2$p. value),] 
## 2C. SAM 
## prostate.cDNA 
datal <- list(x = prostate.cDNA4, y = pdl$grp, 
geneid = rownames(prostate.cDNA4), rownames(prostate.cDNA4), 
logged2=TRUE) 
res.saml <- samr(data = datal, resp.type="Two class unpaired",nperms=50) 
## prostate.Affy 
data2 <- list(x = exprs(prostate.Affy.rmaJ), y = pData(prostate.Affy.rma3)$grp, 
geneid = featureNames(prostate.Affy.rma3), 
genenames=featureN ames(prostate.Affy .rma3), 
logged2=TRUE) 
res.sam2 <- samr( data = data2, resp.type="Two class unpaired" ,nperms=50 ) 
########################################################################### 
## Maybe just take top 1000 genes to comprise gene list 
########################################################################### 
## 3. Take top 1000 genes from each method 
## 3a. T-tests 










ebayes.prostate.cDNA <- topTable(fitcl, adjust.method="BH", number=632) 
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ebayes.prostate.Affy <- topTable(fitc2, adjust.method="BH", number=2000) 
length( intersect( ebayes. prostate. cDN A$ID ,ebayes. prostate.A ffy$ ID) 
## 3c. SAM 
sam.prostate.cDNA <- sort(abs(res.saml $tt), decreasing=TRUE)[l :1031] 
sam.prostate.Affy <- sort(abs(res.sam2$tt), decreasing=TRUE)[1:1181] 
########################################################################### 
## Calculate the expectation value 
########################################################################### 
nsim <- 100 
k.size <- c(50, 100,500, 1000) 
n.subsample <- c( 6,10,20,50) 
pog.E <- array(NA, dim=c( 4, 4, nsim), 
dimnames = list(n.subsample, k.size, 1 :nsim» 
pogr.E <- array(NA, dim=c(4, 4, nsim), 
dimnames = list(n.subsample, k.size, 1 :nsim» 
pogr.E.0.7 <- array(NA, dim=c(4, 4, nsim), 
dimnames = list(n.subsample, k.size, 1 :nsim») 
source("POGR2.R") 
cor.prostate.cDNA <- cor(t(prostate.cDNA4» 
cor. prostate.Affy <- cor( t( exprs(prostate.Affy .rma3»)) 
source("POGR2.R") 
for (i in 1:4) { 
for G in 1 :nsim) { 
set.seed((i * 1 00+j» 
subset. prostate.cDN A.Nor <- which(pd 1 $grp%in%c("Normal ") 
subset. prostate.cDNA. Tur <- which(pd 1 $grp%in%c("Tumor") 
sub.idx.cDNA.Nor <- sample(subset.prostate.cDNA.Nor, n.subsample[i]/4, replace=F ALSE) 
sub.idx.cDNA.Tur <- sample(subset.prostate.cDNA.Tur, n.subsample[i]*3/4, 
replace=F ALSE) 
sub.idx1 <- union(sub.idx.cDNA.Nor, sub.idx.cDNA.Tur) 
sub.prostate.cDNA <- pd1$grp[sub.idx1] 
prostate.cDNA.sub <- prostate.cDNA4[,sub.idx 1] 
## prostate.Affy subsets 
subset.prostate.Affy.Nor <- which(pd2$grp%in%c("Normal"» 
subset. prostate.Affy. Tur <- which(pd2$grp%in%c("Tumor"») 
sub.idx. prostate.Affy.N or <- sample( subset.prostate.Affy .Nor, n.subsample[i ]/2, 
replace=F ALSE) 
sub.idx. prostate.Affy. Tur <- sample( subset. prostate.Affy .Tur, n.subsample[i]/2, 
replace=F ALSE) 
sub. idx2<- union( sub.idx. prostate.Affy.N or, sub.idx. prostate.Affy .Tur) 
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sub.prostate.Affy <- pData(prostate.Affy.rma3)[ sub.idx2,] 
prostate.Affy.sub <- prostate.Affy.rma3[,sub.idx2] 
## 1. Randomly pick two lists (size 1000) 
## head( exprs( all sub 1 )) 
idxl <- sample(l:nrow(prostate.cDNA.sub), 1000, replace=FALSE) 
idx2 <- sample( 1 :nrow(prostate.Affy.sub ), 1000, replace=F ALSE) 
list 1 <- rownames(prostate.cDNA.sub )[idx I] 
list2 <- rownames( exprs(prostate.Affy .sub) )[idx2] 
## Check overlap with original gene list in terms of ranking for top 1000 
## First, simple E[POG] score 
pog.E[i, 4, j] <- length(intersect(listl [I: 1000], list2[1: 1 000]))/1 000 
pog.E[i, 3, j] <- length(intersect(list1 [1 :500], list2(1 :500]))/500 
pog.E[i, 2, j] <- length(intersect(list 1 [1 : 100], list2(1: 100]))/100 
pog.E[i, I, j] <- length(intersect(listl (1 :50], list2[l :50]))/50 
## Now, look at POGR.E score 
## Need to calculate all pairwise correlations between these two sets of genes 
pogr.E[i, 4,j] <- pogr(cor.prostate.cDNA ,cor.prostate.Affy, listl[l:1000], list2[1:1000], 0.5) 
pogr.E[i, 3, j] <- pogr( cor.prostate.cDNA ,cor.prostate.Affy, listl [1 :500], list2[l :500], 0.5) 
pogr.E[i, 2, j] <- pogr( cor.prostate.cDNA ,cor.prostate.Affy, listl[ 1: 100], list2[l: 100], 0.5) 
pogr.E[i, I, j] <- pogr( cor.prostate.cDNA ,cor.prostate.Affy, list1 (1 :50], list2[l :50], 0.5) 
pogr.E.0.7[i, 4,j] <- pogr(cor.prostate.cDNA ,cor.prostate.Affy, listl[l:1000], list2(1:1000], 
0.7) 
pogr.E.0.7[i, 3,j] <- pogr(cor.prostate.cDNA ,cor.prostate.Affy, list1[l:500], list2[l:500], 
0.7) 
pogr.E.0.7[i, 2, j] <- pogr( cor.prostate.cDNA ,cor.prostate.Affy, listl [1: 100], list2(1: 1 00], 
0.65) 
pogr.E.0.7[i, 1,j] <- pogr(cor.prostate.cDNA ,cor.prostate.Affy, listl[l:50], list2[l:50], 0.7) 
}} 
########################################################################### 
## Calculate the scores 
########################################################################### 
nsim <- 50 
k.size <- c(50, 100, 500, 1000) 
n.subsample <- c( 6,10,20,50) 
## Create array to store results (what are they?) 
pog.array <- array(NA, dim=c(3, 4, 4, nsim), 
dimnames = list(c("ttest","ebayes", "SAM"),n.subsample, k.size, l:nsim)) 
pogr.array <- array(NA, dim=c(3, 4, 4, nsim), 
dimnames = list(c("ttest","ebayes", "SAM"),n.subsample, k.size, l:nsim)) 
pogr.array2 <- array(NA, dim=c(3, 4, 4, nsim), 
dimnames = list(c("ttest","ebayes", "SAM"),n.subsample, k.size, I:nsim)) 
npog.array <- array(NA, dim=c(3, 4, 4, nsim), 
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dimnames = list(c("ttest","ebayes", "SAM"),n.subsample, k.size, l:nsim» 
npogr.array <- array(NA, dim=c(3,4, 4, nsim), 
dimnames = list( c("ttest" ,"ebayes", "SAM"),n.subsample, k.size, 1 :nsim» 
npogr.array2 <- array(NA, dim=c(3,4, 4, nsim), 
dimnames = list(c("ttest","ebayes", "SAM"),n.subsample, k.size, 1 :nsim» 
pogr.array.O.7 <- array(NA, dim=c(3, 4, 4, nsim), 
dimnames = list(c("ttest","ebayes", "SAM"),n.subsample, k.size, l:nsim» 
npogr.array.O.7 <- array(NA, dim=c(3, 4, 4, nsim), 
dimnames = list(c("ttest","ebayes", "SAM"),n.subsample, k.size, l:nsim» 
pogr.array2.0.7 <- array(NA, dim=c(3, 4, 4, nsim), 
dimnames = list(c("ttest","ebayes", "SAM"),n.subsample, k.size, 1 :nsim» 
npogr.array2.0.7 <- array(NA, dim=c(3, 4, 4, nsim), 
dimnames = list( c("ttest","ebayes", "SAM"),n.subsample, k.size, I :nsim» 
## To calculate normalized scores 
EPOG <- read.csv("E(pog)prostate.sub.csv") 
EPOGR <- read.csv("E(pogr)prostate.sub.csv") 
## cutoff=O.7 
EPOGR.O.7 <- read.csv("E(pogr)prostate.sub.07.csv") 
## cor matrix for two datasets 
cor.prostate.cDNA <- cor(t(prostate.cDNA4» 
cor.prostate.Affy <- cor( t( exprs(prostate.Affy .rma3))) 
source("POGR2.R") 
for (i in 1:4) { 
for G in 1 :nsim) { 
set.seed((i* 1 OO+j» 
subset.prostate.cDNA.Nor <- which(pdl $grp%in%c("Normal"» 
subset. prostate.cDNA. Tur <- which(pd 1 $grp%in%c("Tumor"» 
sub.idx.cDNA.Nor <- sample(subset.prostate.cDNA.Nor, n.subsample[i]/2, replace=F ALSE) 
sub. idx.cDN A. Tur <- sample( subset. prostate.cDNA. Tur, n.subsample[i]/2, replace=F ALSE) 
sub.idxl <- union(sub.idx.cDNA.Nor, sub.idx.cDNA.Tur) 
sub. prostate.cDN A <- pd 1 $grp[ sub.idx 1] 
prostate.cDNA.sub <- prostate.cDNA4[,sub.idx 1] 
## prostate.Affy subsets 
subset. prostate.Affy.N or <- which(pd2$grp%in%c("Normal "» 
subset.prostate.Affy. Tur <- which(pd2$grp%in%c("Tumor"» 
sub.idx.prostate.Affy.Nor <- sample(subset.prostate.Affy.Nor, n.subsample[i]/2, 
replace=F ALSE) 
sub.idx. prostate.Affy. Tur <- sample( subset. prostate.Affy .Tur, n.subsample[i]/2, 
replace=F ALSE) 
sub.idx2<- union(sub.idx.prostate.Affy.Nor, sub.idx.prostate.Affy.Tur) 
sub.prostate.Affy <- pData(prostate.Affy.rma3)[sub.idx2,] 





## prostate. eDNA 
designl <- model.matrix( ~sub.prostate.eDNA - I) 
eolnames(designl) <- e("Tumor", "Normal") 
eontrl <- makeContrasts(Tumor-Normal, levels=design I) 
## prostate.Affy 
design2 <- model.matrix( ~sub.prostate.Affy - I) 
eolnames(design2) <- e("Tumor", "Normal") 
eontrl <- makeContrasts(Tumor-Normal, levels=design2) 
## prostate.eDNAlett 
ttl <- rowttests(prostate.eDNA.sub, sub.prostate.eDNA) 
ttest.prostate.eDNA <- tt I [order(tt I $p.value ),] 
## prostate.Affy 
tt2 <- rowttests(prostate.Affy.sub, sub.prostate.Affy) 
ttest.prostate.Affy <- tt2[ order(tt2$p. value),] 
## First, simple POG seore 
pog.array["ttest",i,4J] <- length(interseet(rownames(ttest.prostate.eDNA)[I: 1000], 
rownames( ttest.prostate.Affy)[ I : I 000]))/1000 
pog.array["ttest" ,i,3,j] <- length(interseet( rownames( ttest. prostate. eDNA )[ 1:500], 
rownames(ttest.prostate.Affy)[1 :500]))/500 
pog.array["ttest" ,i,2,j] <- length(interseet(rownames(ttest.prostate.eDNA)[ I: I 00], 
rownames(ttest.prostate.Affy)[I: I 00]))/1 00 
pog.array["ttest" ,i, I J] <- length(interseet(rownames(ttest.prostate.eDNA)[1 :50], 
rownames(ttest.prostate.Affy)[1 :50]))/50 
## Normalized POG 
npog.array["ttest" ,i,4J] <- (pog.array["ttest" ,i,4,j] - EPOG[i,4 D/( I-EPOG[i,4]) 
npog.array["ttest",i,3,j] <- (pog.array["ttest",i,3J] - EPOG[i,3D/(I-EPOG[i,3]) 
npog.array["ttest" ,i,2J] <- (pog.array["ttest" ,i,2,j] - EPOG[i,2D/( I-EPOG[i,2]) 
npog.array["ttest" ,i, I J] <- (pog.array["ttest" ,i, I J] - EPOG[i, I D/( I-EPOG[i, I D 
## Now, look at POGR seore 
## eutoff=0.5 
pogr.array["ttest",i,4J] <- pogr(eor.prostate.eDNA,eor.prostate.Affy, 
rownames(ttest.prostate.eDNA)[I: I 000], 
rownames(ttest.prostate.Affy)[I: I 000], 0.5) 
pogr.array["ttest" ,i,3J] <- pogr( eor.prostate.eDNA,eor.prostate.Affy, 
rownames(ttest.prostate.eDNA)[1 :500], 
rownames(ttest.prostate.Affy)[1 :500],0.5) 
pogr.array["ttest",i,2J] <- pogr( eor.prostate.eDNA,eor.prostate.Affy, 
rownames(ttest.prostate.eDNA)[I: I 00], 
rownames(ttest.prostate.Affy)[I: 100], 0.5) 




## Need to also go other direction 
pogr.array2["ttest",i,4,j] <- pogr( cor.prostate.Affy,cor.prostate.cDNA, 
rownames(ttest.prostate.Affy)[1: 1 000], 
rownames(ttest.prostate.cDNA)[1: 1000],0.5) 
pogr.array2["ttest" ,i,3j] <- pogr( cor.prostate.Affy,cor.prostate.cDNA, 
rownames(ttest.prostate.Affy)[l :500], 
rownames(ttest.prostate.cDNA)[l :500],0.5) 
pogr.array2 ["ttest" ,i,2,j] <- pogr( cor. prostate.Affy,cor.prostate.cDNA, 
rownames( ttest.prostate.Affy)[ 1: 100], 
rownames(ttest.prostate.cDNA)[l: 100], 0.5) 
pogr.array2["ttest",i,lj] <- pogr(cor.prostate.Affy,cor.prostate.cDNA, 
rownames(ttest.prostate.Affy)[ 1 :50], 
rownames(ttest.prostate.cDNA)[l :50],0.5) 
npogr.array["ttest",i,4,j] <- (pogr.array["ttest" ,i,4j] - EPOGR[i,4 ])/( I-EPOGR[i,4]) 
npogr.array["ttest",i,3,j] <- (pogr.array["ttest",i,3j] - EPOGR[i,3])/(I-EPOGR[i,3]) 
npogr.array["ttest" ,i,2,j] <- (pogr. array ["ttest II ,i,2,j] - EPOGR[i,2])/( l-EPOGR[i,2]) 
npogr.array["ttest" ,i, I j] <- (pogr.array["ttest" ,i, I ,j] - EPOGR[i, I ])/( l-EPOGR[i, I]) 
npogr.array2["ttest",i,4,j] <- (pogr.array2["ttest",i,4j] - EPOGR[i,4])/(1-EPOGR[i,4]) 
npogr.array2["ttest",i,3,j] <- (pogr.array2["ttest",i,3,j] - EPOGR[i,3])/(l-EPOGR[i,3]) 
npogr.array2["ttest",i,2j] <- (pogr.array2["ttest" ,i,2,j] - EPOGR[i,2])/(l-EPOGR[i,2]) 
npogr.array2["ttest",i,lj] <- (pogr.array2["ttest",i,1,j] - EPOGR[i,I])/(l-EPOGR[i,l]) 
## cutoff=0.7 
pogr.array.O. 7["ttest" ,i,4j] <- pogr( cor.prostate.cDNA,cor.prostate.Affy, 
rownames(ttest.prostate.cDNA)[ 1: 1 000], 
rownames(ttest.prostate.Affy)[l: 1 000], 0.65) 
pogr.array.0.7["ttest",i,3,j] <- pogr(cor.prostate.cDNA,cor.prostate.Affy, 
rownames(ttest.prostate.cDNA)[l :500], 
rownames(ttest.prostate.Affy)[l :500],0.65) 
pogr.array.O. 7["ttest" ,i,2j] <- pogr( cor.prostate.cDNA,cor.prostate.Affy, 
rownames(ttest.prostate.cDNA)[1: 1 00], 
rownames(ttest.prostate.Affy)[l: 100], 0.65) 
pogr.array.O. 7["ttest" ,i, 1 ,j] <- pogr( cor.prostate.cDNA,cor.prostate.Affy, 
rownames(ttest.prostate.cDNA)[1 :50], 
rownames(ttest.prostate.Affy)[l :50],0.65) 
pogr.array2.0.7["ttest",i,4j] <- pogr(cor.prostate.Affy,cor.prostate.cDNA, 
rownames(ttest.prostate.Affy)[l: 1 000], 
rownames(ttest.prostate.cDNA)[1: 1000],0.65) 
pogr.array2.0. 7 ["ttest" ,i,3j] <- pogr( cor.prostate.Affy,cor.prostate.cDNA, 
rownames(ttest.prostate.Affy)[1 :500], 
rownames(ttest.prostate.cDNA)[l :500],0.65) 




pogr.array2.0. 7["ttest",i, I j] <- pogr( eor.prostate.Affy,eor.prostate.eDNA, 
rownames(ttest.prostate.Affy)[1 :50], 
rownames(ttest.prostate.eDNA)[1 :50],0.65) 
npogr.array.0.7["ttest",i,4j] <- (pogr.array.0.7["ttest",i,4,j] - EPOGR[i,4])/(l-EPOGR[i,4]) 
npogr.array.0.7["ttest",i,3j] <- (pogr.array.0.7["ttest",i,3j] - EPOGR[i,3])/(I-EPOGR[i,3]) 
npogr.array .0. 7["ttest" ,i,2j] <- (pogr.array.O. 7["ttest" ,i,2,j] - EPOGR[i,2])/(I-EPOGR[i,2]) 
npogr.array.O. 7["ttest",i, I j] <- (pogr.array.0.7["ttest",i, I ,j] - EPOGR[i,1 ])/(l-EPOGR[i, I]) 
npogr.array2.0. 7["ttest" ,i,4j] <- (pogr.array2.0. 7["ttest" ,i,4,j] - EPOGR[i,4 ])/( I-EPOGR[i,4]) 
npogr.array2.0. 7["ttest" ,i,3j] <- (pogr.array2.0.7["ttest",i,3,j] - EPOGR[i,3])/( I-EPOGR[i,3]) 
npogr.array2.0.7["ttest" ,i,2,j] <- (pogr.array2.0.7["ttest",i,2j] - EPOGR[i,2])/(l-EPOGR[i,2]) 
npogr.array2.0.7["ttest" ,i, I j] <- (pogr.array2.0. 7["ttest",i, I ,j] - EPOGR[i,1 ])/( I-EPOGR[i, I] 
########################################################################### 
## 2B. E-BA YES (LIMMA) METHOD 
########################################################################### 
## prostate.eDNA 
fitl <- ImFit(prostate.eDNA.sub, designl) 
fitel <- eontrasts.fit(fitl, eontrl) 
fite I <- eBayes( fite I) 
ebayes.prostate.eDNA <- topTable(fitel, adjust.method="BH",number=IOOO) 
## prostate.Affy 
fit2 <- ImFit(prostate.Affy.sub, design2) 
fite2 <- eontrasts.fit(fit2, eontr2) 
fite2 <- eBayes(fitc2) 
ebayes.prostate.Affy <- topTable(fite2, adjust.method="BH",number=IOOO) 
## First, simple POG score 
pog.array["ebayes",i,4j] <- length(intersect( ebayes.prostate.cDNA$ID[I: I 000], 
ebayes.prostate.Affy$ID[1: 1 000]))/1 000 
pog.array["ebayes",i,3j] <- length(intersect( ebayes.prostate.cDNA$ID[1 :500], 
ebayes.prostate.Affy$ID[1 :500]))/500 
pog.array["ebayes",i,2j] <- length(intersect( ebayes.prostate.eDNA$ID[1: 1 00], 
ebayes.prostate.Affy$ID[I: 1 00]))/100 
pog.array["ebayes" ,i, 1 j] <- length(interseet( ebayes.prostate.cDNA$ID[1 :50], 
ebayes.prostate.Affy$ID[1 :50])/50 
## Normalized POG 
npog.array["ebayes" ,i,4j] <- (pog.array["ebayes" ,i,4j] - EPOG[i,4 ])/(l-EPOG[i,4]) 
npog.array["ebayes",i,3,j] <- (pog.array["ebayes",i,3j] - EPOG[i,3])/(l-EPOG[i,3]) 
npog.array["ebayes" ,i,2,j] <- (pog.array["ebayes" ,i,2j] - EPOG[i,2])/( I-EPOG[i,2]) 
npog.array["ebayes" ,i, 1 ,j] <- (pog.array["ebayes" ,i, 1 j] - EPOG[i, I ])/( I-EPOG[i, I]) 
## Now, look at POGR score 
## eutoff=0.5 
pogr.array["ebayes" ,i,4,j] <- pogr( eor.prostate.eDNA,eor.prostate.Affy, 
ebayes.prostate.eDNA$ID[I: 1 000], ebayes.prostate.Affy$ID[l: 1 000], 
0.5) 
pogr.array["ebayes" ,i,3,j] <- pogr( eor.prostate.cDNA,eor.prostate.Affy, 
ebayes.prostate.eDNA$ID[1 :500], ebayes.prostate.Affy$ID[1 :500],0.5) 
pogr.array["ebayes" ,i,2j] <- pogr( eor.prostate.eDNA,eor.prostate.Affy, 
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ebayes.prostate.cONA$ID[l: 1 00], ebayes.prostate.Affy$ID[l: 1 00],0.5) 
pogr.array["ebayes" ,i, 1 ,j] <- pogr( cor.prostate.cONA,cor.prostate.Affy, 
ebayes.prostate.cONA$ID[l :50], ebayes.prostate.Affy$ID[l :50], 0.5) 
pogr.array2[" ebayes II ,i,4,j] <- pogr( cor.prostate.Affy,cor.prostate.cONA, 
ebayes.prostate.Affy$ID[l: 1 000], ebayes.prostate.cONA$ID[1: 1 000], 
0.5) 
pogr.array2["ebayes",i,3,j] <- pogr(cor.prostate.Affy,cor.prostate.cONA, 
ebayes.prostate.Affy$ID[l :500], ebayes.prostate.cONA$ID[l :500], 0.5) 
pogr.array2["ebayes" ,i,2,j] <- pogr( cor.prostate.Affy,cor.prostate.cONA, 
ebayes.prostate.Affy$ID[1: 1 00], ebayes.prostate.cONA$ID[l: 1 00], 0.5) 
pogr.array2["ebayes",i, 1 j] <- pogr( cor.prostate.Affy,cor.prostate.cONA, 
ebayes.prostate.Affy$ID[l :50], ebayes.prostate.cONA$ID[1 :50], 0.5) 
npogr.array["ebayes",i,4,j] <- (pogr.array["ebayes",i,4j] - EPOGR[i,4])/(l-EPOGR[i,4]) 
npogr.array["ebayes",i,3j] <- (pogr.array["ebayes",i,3j] - EPOGR[i,3])/(l-EPOGR[i,3]) 
npogr.array["ebayes" ,i,2,j] <- (pogr.array["ebayes" ,i,2j] - EPOGR[i,2])/(l-EPOGR[i,2]) 
npogr.array["ebayes" ,i, l,j] <- (pogr.array["ebayes" ,i, 1 j] - EPOGR[i, 1 ])/( l-EPOGR[i, 1]) 
npogr.array2["ebayes" ,i,4j] <- (pogr.array2["ebayes" ,i,4,j] - EPOGR[i,4 ])/(l-EPOGR[i,4]) 
npogr.array2["ebayes",i,3,j] <- (pogr.array2["ebayes",i,3,j] - EPOGR[i,3])/(1-EPOGR[i,3]) 
npogr.array2["ebayes",i,2,j] <- (pogr.array2["ebayes",i,2,j] - EPOGR[i,2])/(l-EPOGR[i,2]) 
npogr.array2["ebayes",i,1,j] <- (pogr.array2["ebayes",i,lj] - EPOGR[i,l])/(l-EPOGR[i,l]) 
## cutoff=0.7 
pogr.array.O. 7 ["ebayes " ,i,4j] <- pogr( cor.prostate.cONA,cor.prostate.Affy, 
ebayes.prostate.cONA$ID[ 1: 1 000], ebayes.prostate.Affy$ID[ 1: 1 000], 
0.65) 
pogr.array.O. 7["ebayes" ,i,3 j] <- pogr( cor. prostate. cON A, cor. prostate.Affy, 
ebayes.prostate.cONA$ID[1 :500], ebayes.prostate.Affy$ID[l :500],0.65) 
pogr.array.O. 7["ebayes" ,i,2j] <- pogr( cor.prostate.cONA,cor.prostate.Affy, 
ebayes.prostate.cONA$ID[ 1: 1 00], ebayes.prostate.Affy$ID[l: 1 00], 0.65) 
pogr.array.O. 7["ebayes" ,i, 1 j] <- pogr( cor.prostate.cONA,cor.prostate.Affy, 
ebayes.prostate.cONA$ID[l :50], ebayes.prostate.Affy$ID[l :50], 0.65) 
pogr.array2.0.7["ebayes",i,4j] <- pogr(cor.prostate.Affy,cor.prostate.cONA, 
ebayes.prostate.Affy$ID[ 1: 1 000], ebayes.prostate.cONA$ID[ 1: 1 000], 
0.65) 
pogr.array2.0.7["ebayes",i,3j] <- pogr(cor.prostate.Affy,cor.prostate.cONA, 
ebayes.prostate.Affy$ID[l :500], ebayes.prostate.cONA$ID[l :500], 
0.65) 
pogr.array2.0.7["ebayes",i,2j] <- pogr(cor.prostate.Affy,cor.prostate.cONA, 
ebayes.prostate.Affy$ID[l: 1 00], ebayes.prostate.cONA$ID[l: 1 00], 
0.65) 
pogr.array2.0. 7["ebayes" ,i, 1 j] <- pogr( cor.prostate.Affy,cor.prostate.cONA, 
ebayes.prostate.Affy$ID[l :50], ebayes.prostate.cONA$ID[ 1 :50], 0.65) 
npogr.array.0.7["ebayes",i,4j] <- (pogr.array.0.7["ebayes",i,4,j] -
EPOGR.O. 7[i,4 ])/( l-EPOGR.O. 7[i,4]) 
npogr.array.0.7["ebayes",i,3j] <- (pogr.array.0.7["ebayes",i,3j] -
EPOGR.0.7[i,3])/(1-EPOGR.0.7[i,3]) 




EPOGR.0.7[i, I ])/(I-EPOGR.0.7[i,l]) 
npogr.array2.0. 7["ebayes" ,i,4,j] <- (pogr.array2.0. 7["ebayes" ,i,4J] -
EPOGR.O. 7[i,4 ])/( I-EPOGR.O. 7[i,4]) 
npogr.array2.0.7["ebayes",i,3,j] <- (pogr.array2.0.7["ebayes",i,3J] -
EPOGR.O. 7[i,3])/( I-EPOGR.O. 7[i,3]) 
npogr.array2.0. 7["ebayes" ,i,2,j] <- (pogr.array2.0. 7["ebayes" ,i,2J] -
EPOGR.O. 7[i,2])/( I-EPOGR.O. 7[i,2]) 
npogr.array2.0. 7["ebayes",i, I ,j] <- (pogr.array2.0. 7["ebayes" ,i, I J] -
EPOGR.O. 7[i, I ])/( I-EPOGR.O. 7[i, I]) 
########################################################################### 
## 2e. SAM 
########################################################################### 
## prostate.eDNA 
datal <- list(x = prostate.eDNA.sub, y = sub. prostate. eDNA, 
geneid = rownames(prostate.eDNA.sub), 
genenames=rownames(prostate.eDNA.sub ), 
logged2=TRUE) 
res.saml <- samr(data = datal, resp.type="Two class unpaired",nperms=50) 
sam. prostate. eDNA <- sort( abs(res.sam I $tt), deereasing=TRUE)[ I: 1000] 
## prostate.Affy 
data2 <-list(x = exprs(prostate.Affy.sub), y = sub.prostate.Affy, 
geneid = featureNames(prostate.Affy.rma3), 
genenames=featureN ames(prostate.Affy .rma3), 
logged2=TRUE) 
res.sam2 <- samr(data = data2, resp.type="Two class unpaired",nperms=50) 
sam. prostate.Affy <- sort( abs( res.sam2$tt), deereasing=TRUE)[1: I 000] 
## First, simple POG score 
pog.array["SAM" ,i,4J] <- length(interseet(names(sam.prostate.eDNA)[ I: I 000], 
names( sam. prostate.Affy)[ I: I 000]))/1 000 
pog.array["SAM",i,3J] <- length(interseet(names(sam.prostate.eDNA)[1 :500], 
names(sam.prostate.Affy)[1 :500]))/500 
pog.array["SAM" ,i,2J] <- length(interseet( names( sam. prostate. eDNA )[ I : I 00], 
names(sam.prostate.Affy)[I: 1 00])/1 00 
pog.array["SAM",i, I J] <- length(interseet(names(sam.prostate.eDNA)[1 :50], 
names(sam.prostate.Affy)[ 1:50])/50 
## Normalized POG 
npog.array[" SAM" ,i,4J] <- (pog.array["SAM" ,i,4J] - EPOG[i,4])/( I-EPOG[i,4]) 
npog.array["SAM",i,3,j] <- (pog.array["SAM",i,3J] - EPOG[i,3])/(I-EPOG[i,3]) 
npog.array["SAM" ,i,2,j] <- (pog.array["SAM" ,i,2J] - EPOG[i,2])/( I-EPOG[i,2]) 
npog.array["SAM" ,i, I ,j] <- (pog.array["SAM" ,i, I J] - EPOG[i, I ])/( I-EPOG[i, I]) 
## Now, look at POGR score 
## eutoff=0.5 
pogr.array["SAM" ,i,4,j] <- pogr( eor.prostate.eDNA,eor.prostate.Affy, 
names(sam.prostate.eDNA)[1 :1000], names(sam.prostate.Affy)[1 :1000], 
0.5) 
pogr.array["SAM" ,i,3,j] <- pogr( eor.prostate.eDNA,eor.prostate.Affy, 
names(sam.prostate.eDNA)[1 :500], names(sam.prostate.Affy)[1 :500], 
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0.5) 
pogr.array["SAM" ,i,2,j] <- pogr( cor.prostate.cDNA,cor.prostate.Affy, 
names(sam.prostate.cDNA)[l: 100], names(sam.prostate.Affy)[l: 100], 
0.5) 
pogr. array[" SAM", i, 1 ,j] <- pogr( cor. prostate.cDN A, cor. prostate.Affy, 
names(sam.prostate.cDNA)[1 :50], names(sam.prostate.Affy)[l :50], 0.5) 
pogr.array2["SAM" ,i,4,j] <- pogr( cor.prostate.Affy,cor.prostate.cDNA, 
names(sam.prostate.Affy)[l: 1 OOO],names(sam.prostate.cDNA)[l: 1000], 
0.5) 
pogr.array2["SAM",i,3,j] <- pogr(cor.prostate.Affy,cor.prostate.cDNA, 
names(sam.prostate.Affy)[l :500],names(sam.prostate.cDNA)[1 :500], 
0.5) 
pogr.array2["SAM",i,2j] <- pogr( cor.prostate.Affy,cor.prostate.cDNA, 
names(sam.prostate.Affy)[ 1: 1 OO],names(sam.prostate.cDNA)[l: 100], 
0.5) 
pogr.array2["SAM",i,1,j] <- pogr(cor.prostate.Affy,cor.prostate.cDNA, 
names(sam.prostate.Affy)[1 :50],names(sam.prostate.cDNA)[1 :50], 0.5) 
npogr.array["SAM" ,i,4,j] <- (pogr.array["SAM" ,i,4j] - EPOGR[i,4 ])/( 1-EPOGR[i,4]) 
npogr.array["SAM",i,3,j] <- (pogr.array["SAM",i,3,j] - EPOGR[i,3])/(1-EPOGR[i,3]) 
npogr.array["SAM" ,i,2,j] <- (pogr.array["SAM",i,2,j] - EPOGR[i,2])/(l-EPOGR[i,2]) 
npogr.array["SAM" ,i, 1 ,j] <- (pogr.array["SAM" ,i, 1 j] - EPOGR[i, 1 ])/( 1-EPOGR[i, 1]) 
npogr.array2["SAM" ,i,4,j] <- (pogr.array2["SAM" ,i,4j] - EPOGR[i,4 ])/( 1-EPOGR[i,4]) 
npogr.array2["SAM",i,3j] <- (pogr.array2["SAM",i,3,j] - EPOGR[i,3])/(1-EPOGR[i,3]) 
npogr.array2["SAM" ,i,2,j] <- (pogr.array2["SAM",i,2j] - EPOGR[i,2])/( 1-EPOGR[i,2]) 
npogr.array2["SAM" ,i, 1 ,j] <- (pogr.array2["SAM" ,i, 1 ,j] - EPOGR[i, 1 ])/( 1-EPOGR[i, 1]) 
## cutoff=0.7 
pogr.array.0.7["SAM",i,4j] <- pogr( cor.prostate.cDNA,cor.prostate.Affy, 
names(sam.prostate.cDNA)[1:1 000], names(sam.prostate.Affy)[l: 1 000], 
0.65) 
pogr.array.0.7["SAM",i,3j] <- pogr(cor.prostate.cDNA,cor.prostate.Affy, 
names(sam.prostate.cDNA)[1 :500], names(sam.prostate.Affy)[l :500], 
0.65) 
pogr.array.0.7["SAM",i,2j] <- pogr(cor.prostate.cDNA,cor.prostate.Affy, 
names(sam.prostate.cDNA)[l :100], names(sam.prostate.Affy)[l: 100], 
0.65) 
pogr.array.0.7["SAM" ,i, 1 ,j] <- pogr( cor.prostate.cDNA,cor.prostate.Affy, 
names(sam.prostate.cDNA)[1 :50], names(sam.prostate.Affy)[1 :50],0.65) 
pogr.array2.0. 7["SAM" ,i,4,j] <-pogr( cor. prostate.Affy,cor. prostate. eDNA, 
names(sam.prostate.Affy)[I: 1 OOO],names(sam.prostate.cDNA)[I: 1 000], 
0.65) 
pogr.array2.0. 7["SAM" ,i,3,j] <-pogr( cor.prostate.Affy,cor.prostate.cDNA, 
names(sam.prostate.Affy)[ 1 :500],names(sam.prostate.cDNA)[ 1 :500], 
0.65) 
pogr.array2.0. 7["SAM" ,i,2,j] <-pogr( cor.prostate.Affy,cor. prostate. eDNA, 
names(sam.prostate.Affy)[I: 1 OO],names(sam.prostate.cDNA)[I: 100], 
0.65) 
pogr.array2.0. 7["SAM",i, 1 ,j] <-pogr( cor.prostate.Affy,cor.prostate.cDNA, 
names(sam.prostate.Affy)[1 :50],names(sam.prostate.cDNA)[1 :50], 
0.65) 
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npogr.array.0.7["SAM",i,4,j] <- (pogr.array.0.7["SAM",i,4,j] -
EPOGR.0.7[i,4])/(I-EPOGR.0.7[i,4]) 
npogr.array.0.7["SAM",i,3,j] <- (pogr.array.0.7["SAM",i,3,j] -
EPOGR.0.7[i,3])/(I-EPOGR.0.7[i,3]) 
npogr.array.0.7["SAM",i,2,j] <- (pogr.array.0.7["SAM",i,2j] -
EPOGR.O. 7[i,2])/( l-EPOGR.O. 7[i,2]) 
npogr.array.O. 7["SAM" ,i, 1 ,j] <- (pogr.array.O. 7["SAM",i, 1 ,j] -
EPOGR.0.7[i, 1 ])/(I-EPOGR.O. 7[i, 1]) 
npogr.array2.0.7["SAM",i,4j] <- (pogr.array2.0.7["SAM",i,4,j] -
EPOGR.O. 7 [i,4])/( l-EPOGR.O. 7[i,4]) 
npogr.array2.0.7["SAM",i,3,j] <- (pogr.array2.0.7["SAM",i,3,j] -
EPOGR.0.7[i,3])/(I-EPOGR.0.7[i,3]) 
npogr.array2.0.7["SAM",i,2,j] <- (pogr.array2.0. 7["SAM" ,i,2,j] -
EPOGR.O. 7[i,2])/( l-EPOGR.O. 7[i,2]) 
npogr.array2.0. 7["SAM",i, 1 ,j] <- (pogr.array2.0. 7["SAM",i, 1 j] -
EPOGR.O. 7[i, 1 ])/(l-EPOGR.O. 7[i, 1]) 
}} 
##################################################################### 




nPOG.DMD <- read.csv("npog DMD.sub.csv") 
nPOG.Lung <- read.csv("npog lung.sub.csv") 
nPOG.Prostate <- read.csv("npog prostate.sub.csv") 
## Plot all using lattice - xyplot 
npog.DMD.mean <- rowMeans(nPOG.DMD) 
npog.Lung.mean <- rowMeans(nPOG.Lung) 
npog.Prostate.mean <- rowMeans(nPOG.Prostate) 
plot.df <- data.frame(npog = c(npog.DMD.mean, npog.Lung.mean, npog.Prostate.mean), 
data = rep(c("DMD", "Lung cancer", "Prostate cancer"), each=12), 
subset = c(rep(c(6, 12, 18, 24),3),rep(c(4, 8, 12, 16),3), 
rep( c(6, I 0,20,50),3)), 
method = rep(rep(c("t-test","eBayes","SAM"), each=4), 3)) 
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xyplot(npog~subset I data, groups = method, type="l", data=plot.df, 
auto.key=list(columns=3,titie="nPOG score for detecting DEG lists from different 
datasets of the same diseases" ),layout=c(3,1), 
scales=list(x=list(at=c(4,8,12,18,24,50») ) 
## nPOGR 
nPOGR.DMD <- read.csv("npogr DMD.sub.csv") 
nPOGR.Lung <- read.csv("npogr lung.sub.csv") 
nPOGR.Prostate <- read.csv("npogr prostate.sub.csv") 
## Plot all using lattice - xyplot 
npogr.DMD.mean <- rowMeans(nPOGR.DMD) 
npogr.Lung.mean <- rowMeans(nPOGR.Lung) 
npogr.Prostate.mean <- rowMeans(nPOGR.Prostate) 
plot.df <- data.frame(npogr = c(npogr.DMD.mean, npogr.Lung.mean, npogr.Prostate.mean), 
data = rep(c("DMD", "Lung cancer", "Prostate cancer"), each=12), 
subset = c(rep(c(6, 12, 18, 24),3),rep(c(4, 8, 12, 16),3), 
rep( c(6, 1 0,20,50),3», 
method = rep(rep(c("t-test", "eBayes", "SAM"), each=4), 3» 
xyplot(npogr~subset I data, groups = method, type="l", data=plot.df, 
auto.key=list( columns=3),layout=c(3, 1), 
scales=list(x=list(at=c( 4,8,12,18,24,50) » ) 
##nPOGR2 
nPOGR2.DMD <- read.csv("npogr2 DMD.sub.csv") 
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nPOGR2.Lung <- read.csv("npogr2 lung.sub.csv") 
nPOGR2.Prostate <- read.csv("npogr2 prostate.sub.csv") 
## Plot all using lattice - xyplot 
npogr2.DMD.mean <- rowMeans(nPOGR2.DMD) 
npogr2.Lung.mean <- rowMeans(nPOGR2.Lung) 
npogr2.Prostate.mean <- rowMeans(nPOGR2.Prostate) 
plot.df <- data.frame(npogr2 = c(npogr2.DMD.mean, npogr2.Lung.mean, 
npogr2.Prostate.mean), 
data = rep(c("DMD", "Lung cancer", "Prostate cancer"), each=12), 
subset = c(rep(c(6, 12, 18, 24),3),rep(c(4, 8,12,16),3), 
rep( c( 6,10,20,50),3)), 
method = rep(rep(c("t-test", "eBayes", "SAM"), each=4), 3)) 
xyplot(npogr2~subset I data, groups = method, type="l", data=plot.df, 
auto.key=list( columns=3),layout=c(3, 1), 
scales=list(x=list( at=c( 4,8,12,18,24,50) )) ) 
## nPOGR 0.75 
nPOGR.DMD.0.75 <- read.csv("npogr 0.75 DMD.sub.csv") 
nPOGR.Lung.0.75 <- read.csv("npogr 0.75 lung.sub.csv") 
nPOGR.Prostate.0.75 <- read.csv("npogr 0.7 prostate.sub.csv") 
## Plot all using lattice - xyplot 
npogr.DMD.0.75.mean <- rowMeans(nPOGR.DMD.0.75) 
npogr.Lung.0.75.mean <- rowMeans(nPOGR.Lung.0.75) 
npogr.Prostate.0.75.mean <- rowMeans(nPOGR.Prostate.0.75) 
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plot.df <- data.frame(npogr.0.75 = c(npogr.DMD.0.75.mean, npogr.Lung.0.75.mean, 
npogr.Prostate.0.75.mean), 
data = rep(c("DMD", "Lung cancer", "Prostate cancer"), each=12), 
subset = c(rep(c(6, 12, 18, 24),3),rep(c(4, 8,12, 16),3), 
rep( c(6, 1 0,20,50),3)), 
method = rep(rep(c("t-test", "eBayes", "SAM"), each=4), 3)) 
xyplot(npogr.0.75~subset I data, groups = method, type="l", data=plot.df, 
auto.key=list(columns=3,titie="nPOGR score form listl to list2 (cutoff= 
0.75)"),layout=c(3,1 ), 
scales=list(x=list( at=c( 4,8,12,18,24,50) » ) 
## nPOGR2 0.75 
nPOGR2.DMD.0.75 <- read.csv("npogr2 0.75 DMD.sub.csv") 
nPOGR2.Lung.0.75 <- read.csv("npogr2 0.75 lung.sub.csv") 
nPOGR2.Prostate.0.75 <- read.csv("npogr2 0.7 prostate.sub.csv") 
## Plot all using lattice - xyplot 
npogr2.DMD.0.75.mean <- rowMeans(nPOGR2.DMD.0.75) 
npogr2.Lung.0.75.mean <- rowMeans(nPOGR2.Lung.0.75) 
npogr2.Prostate.0.75.mean <- rowMeans(nPOGR2.Prostate.0.75) 
plot.df <- data.frame(npogr2.0.75 = c(npogr2.DMD.0.75.mean, npogr2.Lung.0.75.mean, 
npogr2.Prostate.0. 75 .mean), 
data = rep(c("DMD", "Lung cancer", "Prostate cancer"), each=12), 
subset = c(rep(c(6, 12, 18, 24),3),rep(c(4, 8, 12,16),3), 
rep( c(6, 10,20,50),3)), 
method = rep(rep(c("t-test", "eBayes", "SAM"), each=4), 3)) 
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xyplot(npogr2.0.75~subset I data, groups = method, type="l", data=plot.df, 
auto.key=list( columns=3,title="nPOGR score form list2 to listl (cutoff= 
0.75)"),layout=c(3,1 ), 
scales=list(x=list( at=c( 4,8,12,18,24,50) )) ) 
##################################################################### 
## The End 
##################################################################### 
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